{"id":2270,"date":"2023-12-06T20:40:46","date_gmt":"2023-12-06T12:40:46","guid":{"rendered":"https:\/\/cathayvista.top\/?p=2270"},"modified":"2025-01-31T13:59:01","modified_gmt":"2025-01-31T05:59:01","slug":"crohns-disease-en","status":"publish","type":"post","link":"https:\/\/cathayvista.top\/index.php\/2023\/12\/06\/crohns-disease-en\/","title":{"rendered":"\u514b\u7f57\u6069\u75c5 \/ \u514b\u9686\u6c0f\u75c7 \/ Crohn’s disease – \u82f1\u6587\u7ef4\u57fa\u767e\u79d1\u8bcd\u6761"},"content":{"rendered":"\n
\n

\u82f1\u6587\u8bcd\u6761\u539f\u6587\u94fe\u63a5\uff08\u65e0\u6cd5\u4ece\u4e2d\u56fd\u5185\u5730\u8bbf\u95ee\uff09\uff1a\u70b9\u51fb\u8fd9\u91cc\u8bbf\u95ee<\/a>\u3002
\u8fbd\u89c2\u642c\u8fd0\u65f6\u8fdb\u884c\u4e86\u5fc5\u8981\u7684\u5408\u89c4\u5316\u5904\u7406\uff0c\u4ee5\u4f7f\u5176\u80fd\u591f\u5728\u4e2d\u56fd\u5185\u5730\u4e0a\u4f20\u3002<\/p>\n\n\n\n

\u7ef4\u57fa\u767e\u79d1\uff08Wikipedia\uff09\u662f\u7f8e\u56fd\u7ef4\u57fa\u5a92\u4f53\u57fa\u91d1\u4f1a\u7684\u4e92\u8054\u7f51\u767e\u79d1\u9879\u76ee\uff0c\u5176\u5185\u5bb9\u53ef\u80fd\u53d7\u5230\u7acb\u573a\u3001\u4fe1\u606f\u6765\u6e90\u7b49\u56e0\u7d20\u5f71\u54cd\uff0c\u8bf7\u5ba2\u89c2\u770b\u5f85\u3002\u6b63\u6587\u5185\u5bb9\u4e0d\u4ee3\u8868\u8bd1\u8005\u89c2\u70b9\u3002<\/p>\n\n\n\n

\u8fbd\u89c2\u63d0\u4f9b\u7684\u7ffb\u8bd1\u4ec5\u4f9b\u53c2\u8003\u3002\u6587\u4e2d\u53ef\u80fd\u5305\u542b\u65e0\u6cd5\u4ece\u4e2d\u56fd\u5185\u5730\u8bbf\u95ee\u7684\u94fe\u63a5\u3002<\/strong><\/p>\n\u8fbd\u89c2\u642c\u8fd0\u3001\u7ffb\u8bd1\u3001\u6574\u5408\u7684\u4e2d\u82f1\u6587\u7ef4\u57fa\u767e\u79d1\u8bcd\u6761\u3002\u4e0e\u539f\u7ef4\u57fa\u767e\u79d1\u8bcd\u6761\u540c\u6837\u9075\u5faaCC-BY-SA 4.0\u534f\u8bae<\/a>\uff0c\u5728\u7b26\u5408\u534f\u8bae\u8981\u6c42\u7684\u60c5\u51b5\u4e0b\u60a8\u53ef\u4ee5\u514d\u8d39\u4f7f\u7528\u5176\u5185\u5bb9\uff08\u5305\u62ec\u5546\u7528\uff09\u3002 \u56fe\u7247\u548c\u89c6\u9891\u53ef\u80fd\u9075\u5faa\u4e0d\u540c\u7684\u534f\u8bae\uff0c\u8be6\u89c1\u672c\u6587\u6d89\u53ca\u7684\u5171\u4eab\u534f\u8bae<\/a><\/cite><\/blockquote>\n\n\n\n

1. \u6b63\u6587\uff08\u53d1\u5e03\u4e8e\u77e5\u4e4e\u4e13\u680f\uff09<\/h2>\n\n\n\n

\u8bf7\u70b9\u51fb\u8fd9\u91cc\u8bbf\u95ee<\/a><\/p>\n\n\n\n

2. \u53c2\u8003\u6587\u732e References<\/h2>\n\n\n\n
    \n
  1. \u00b7  Baumgart DC, Sandborn WJ (August 2012). “Crohn’s disease”<\/a>. Lancet. 380<\/strong> (9853): 1590\u2013605. doi<\/a>:10.1016\/S0140-6736(12)60026-9<\/a>. PMID<\/a> 22914295<\/a>.<\/em><\/li>\n\n\n\n
  2. \u00b7  “Crohn’s disease”<\/a>. Autoimmune Registry Inc. Archived<\/a> from the original on June 15, 2022. Retrieved June 15, 2022.<\/em><\/li>\n\n\n\n
  3. \u00b7  “Crohn’s Disease”<\/a>. National Institute of Diabetes and Digestive and Kidney Diseases<\/a> (NIDDK). Archived from the original<\/a> on December 8, 2019. Retrieved December 8, 2019.<\/em><\/li>\n\n\n\n
  4. \u00b7  Cosnes J (June 2004). “Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice”. Best Practice & Research. Clinical Gastroenterology. 18<\/strong> (3): 481\u201396. doi<\/a>:10.1016\/j.bpg.2003.12.003<\/a>. PMID<\/a> 15157822<\/a>.<\/em><\/li>\n\n\n\n
  5. \u00b7  “Inflammatory Bowel Disease”<\/a> (PDF). World Gastroenterology Organization. August 2015. Archived from the original<\/a> (PDF) on March 14, 2016. Retrieved March 13, 2016.<\/em><\/li>\n\n\n\n
  6. \u00b7  Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE (April 2018). “ACG Clinical Guideline: Management of Crohn’s Disease in Adults”. The American Journal of Gastroenterology. 113<\/strong> (4): 481\u2013517. doi<\/a>:10.1038\/ajg.2018.27<\/a>. PMID<\/a> 29610508<\/a>. S2CID<\/a> 4568430<\/a>.<\/em><\/li>\n\n\n\n
  7. \u00b7  Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG (January 2012). “Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review”<\/a>. Gastroenterology. 142<\/strong> (1): 46\u201354.e42, quiz e30. doi<\/a>:10.1053\/j.gastro.2011.10.001<\/a>. PMID<\/a> 22001864<\/a>. S2CID<\/a> 206223870<\/a>. Archived<\/a> from the original on October 7, 2022. Retrieved October 7, 2022.<\/em><\/li>\n\n\n\n
  8. \u00b7  Cho JH, Brant SR (May 2011). “Recent insights into the genetics of inflammatory bowel disease”<\/a>. Gastroenterology. 140<\/strong> (6): 1704\u201312. doi<\/a>:10.1053\/j.gastro.2011.02.046<\/a>. PMC<\/a> 4947143<\/a>. PMID<\/a> 21530736<\/a>.<\/em><\/li>\n\n\n\n
  9. \u00b7  Dessein R, Chamaillard M, Danese S (September 2008). “Innate immunity in Crohn’s disease: the reverse side of the medal”. Journal of Clinical Gastroenterology. 42<\/strong> (Suppl 3 Pt 1): S144\u20137. doi<\/a>:10.1097\/MCG.0b013e3181662c90<\/a>. PMID<\/a> 18806708<\/a>.<\/em><\/li>\n\n\n\n
  10. \u00b7  Stefanelli T, Malesci A, Repici A, Vetrano S, Danese S (May 2008). “New insights into inflammatory bowel disease pathophysiology: paving the way for novel therapeutic targets”. Current Drug Targets. 9<\/strong> (5): 413\u20138. doi<\/a>:10.2174\/138945008784221170<\/a>. PMID<\/a> 18473770<\/a>.<\/em><\/li>\n\n\n\n
  11. \u00b7  Marks DJ, Rahman FZ, Sewell GW, Segal AW (February 2010). “Crohn’s disease: an immune deficiency state”<\/a>. Clinical Reviews in Allergy & Immunology. 38<\/strong> (1): 20\u201331. doi<\/a>:10.1007\/s12016-009-8133-2<\/a>. PMC<\/a> 4568313<\/a>. PMID<\/a> 19437144<\/a>.<\/em><\/li>\n\n\n\n
  12. \u00b7  Casanova JL, Abel L (August 2009). “Revisiting Crohn’s disease as a primary immunodeficiency of macrophages”<\/a>. The Journal of Experimental Medicine. 206<\/strong> (9): 1839\u201343. doi<\/a>:10.1084\/jem.20091683<\/a>. PMC<\/a> 2737171<\/a>. PMID<\/a> 19687225<\/a>.<\/em><\/li>\n\n\n\n
  13. \u00b7  Lalande JD, Behr MA (July 2010). “Mycobacteria in Crohn’s disease: how innate immune deficiency may result in chronic inflammation”. Expert Review of Clinical Immunology. 6<\/strong> (4): 633\u201341. doi<\/a>:10.1586\/eci.10.29<\/a>. PMID<\/a> 20594136<\/a>. S2CID<\/a> 25402952<\/a>.<\/em><\/li>\n\n\n\n
  14. \u00b7  Yamamoto-Furusho JK, Korzenik JR (November 2006). “Crohn’s disease: innate immunodeficiency?”<\/a>. World Journal of Gastroenterology. 12<\/strong> (42): 6751\u20135. doi<\/a>:10.3748\/wjg.v12.i42.6751<\/a>. PMC<\/a> 4087427<\/a>. PMID<\/a> 17106921<\/a>.<\/em><\/li>\n\n\n\n
  15. \u00b7  Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, et al. (August 2008). “Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease”<\/a>. Nature Genetics. 40<\/strong> (8): 955\u201362. doi<\/a>:10.1038\/ng.175<\/a>. PMC<\/a> 2574810<\/a>. PMID<\/a> 18587394<\/a>.<\/em><\/li>\n\n\n\n
  16. \u00b7  Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC (August 2012). “Inflammatory bowel disease in Asia: a systematic review”<\/a>. Journal of Gastroenterology and Hepatology. 27<\/strong> (8): 1266\u201380. doi<\/a>:10.1111\/j.1440-1746.2012.07150.x<\/a>. PMID<\/a> 22497584<\/a>. S2CID<\/a> 205468282<\/a>.<\/em><\/li>\n\n\n\n
  17. \u00b7  Hovde \u00d8, Moum BA (April 2012). “Epidemiology and clinical course of Crohn’s disease: results from observational studies”<\/a>. World Journal of Gastroenterology. 18<\/strong> (15): 1723\u201331. doi<\/a>:10.3748\/wjg.v18.i15.1723<\/a>. PMC<\/a> 3332285<\/a>. PMID<\/a> 22553396<\/a>.<\/em><\/li>\n\n\n\n
  18. \u00b7  Burisch J, Munkholm P (July 2013). “Inflammatory bowel disease epidemiology”. Current Opinion in Gastroenterology. 29<\/strong> (4): 357\u201362. doi<\/a>:10.1097\/MOG.0b013e32836229fb<\/a>. PMID<\/a> 23695429<\/a>. S2CID<\/a> 9538639<\/a>.<\/em><\/li>\n\n\n\n
  19. \u00b7  GBD 2015 Mortality Causes of Death Collaborators (October 2016). “Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015”<\/a>. The Lancet. 388<\/strong> (10053): 1459\u20131544. doi<\/a>:10.1016\/S0140-6736(16)31012-1<\/a>. PMC<\/a> 5388903<\/a>. PMID<\/a> 27733281<\/a>.<\/em><\/li>\n\n\n\n
  20. \u00b7  Shih, I-Lun; Lee, Tsung-Chun; Tu, Chia-Hung; Chang, Chin-Chen; Wang, Yu-Fen; Tseng, Yao-Hui; Chiu, Han-Mo; Wu, Ming-Shiang; Wang, Hsiu-Po; Shih, Tiffany Ting-Fang; Liu, Kao-Lang (December 1, 2016). “Intraobserver and interobserver agreement for identifying extraluminal manifestations of Crohn’s disease with magnetic resonance enterography”<\/a>. Advances in Digestive Medicine. 3<\/strong> (4): 174\u2013180. doi<\/a>:10.1016\/j.aidm.2015.05.004<\/a>. S2CID<\/a> 70796090<\/a>.<\/em><\/li>\n\n\n\n
  21. \u00b7  “Crohn’s Disease: Get Facts on Symptoms and Diet”<\/a>. eMedicineHealth. Archived<\/a> from the original on October 20, 2007.<\/em><\/li>\n\n\n\n
  22. \u00b7  Crohn BB, Ginzburg L, Oppenheimer GD (May 2000). “Regional ileitis: a pathologic and clinical entity. 1932”. The Mount Sinai Journal of Medicine, New York. 67<\/strong> (3): 263\u20138. PMID<\/a> 10828911<\/a>.<\/em><\/li>\n\n\n\n
  23. \u00b7  Van Hootegem, Philippe; Travis, Simon (July 9, 2020). “Is Crohn’s Disease a Rightly Used Eponym?”<\/a>. Journal of Crohn’s and Colitis. 14<\/strong> (6): 867\u2013871. doi<\/a>:10.1093\/ecco-jcc\/jjz183<\/a>. ISSN<\/a> 1873-9946<\/a>. PMID<\/a> 31701137<\/a>.<\/em><\/li>\n\n\n\n
  24. \u00b7  Mulder, Daniel J.; Noble, Angela J.; Justinich, Christopher J.; Duffin, Jacalyn M. (May 2014). “A tale of two diseases: The history of inflammatory bowel disease”<\/a>. Journal of Crohn’s and Colitis. 8<\/strong> (5): 341\u2013348. doi<\/a>:10.1016\/j.crohns.2013.09.009<\/a>. PMID<\/a> 24094598<\/a>. S2CID<\/a> 13714394<\/a>.<\/em><\/li>\n\n\n\n
  25. \u00b7  Ginzburg, Leon (May 1986). “Regional enteritis: Historical perspective”<\/a>. Gastroenterology. 90<\/strong> (5): 1310\u20131311. doi<\/a>:10.1016\/0016-5085(86)90419-1<\/a>. PMID<\/a> 3514360<\/a>.<\/em><\/li>\n\n\n\n
  26. \u00b7  internetmedicin.se > Inflammatorisk tarmsjukdom, kronisk, IBD<\/a> By Robert L\u00f6fberg. Retrieved Oct 2010 Translate.<\/a><\/li>\n\n\n\n
  27. \u00b7  Hanauer SB, Sandborn W (March 2001). “Management of Crohn’s disease in adults”<\/a>. The American Journal of Gastroenterology. 96<\/strong> (3): 635\u201343. doi<\/a>:10.1111\/j.1572-0241.2001.3671_c.x<\/a> (inactive August 1, 2023). PMID<\/a> 11280528<\/a>. S2CID<\/a> 31219115<\/a>.<\/em><\/li>\n\n\n\n
  28. \u00b7  Pimentel M, Chang M, Chow EJ, Tabibzadeh S, Kirit-Kiriak V, Targan SR, Lin HC (December 2000). “Identification of a prodromal period in Crohn’s disease but not ulcerative colitis”. The American Journal of Gastroenterology. 95<\/strong> (12): 3458\u201362. doi<\/a>:10.1111\/j.1572-0241.2000.03361.x<\/a>. PMID<\/a> 11151877<\/a>. S2CID<\/a> 2764694<\/a>.<\/em><\/li>\n\n\n\n
  29. \u00b7  National Research Council (2003). “Johne’s Disease and Crohn’s Disease”<\/a>. Diagnosis and Control of Johne’s Disease. Washington, DC: National Academies Press. doi<\/a>:10.17226\/10625<\/a>. ISBN<\/a> 978-0-309-08611-0<\/a>. PMID<\/a> 25032299<\/a>. Bookshelf ID: NBK207651. Archived<\/a> from the original on September 6, 2017. Retrieved August 30, 2017.<\/em><\/li>\n\n\n\n
  30. \u00b7  Taylor BA, Williams GT, Hughes LE, Rhodes J (August 1989). “The histology of anal skin tags in Crohn’s disease: an aid to confirmation of the diagnosis”. International Journal of Colorectal Disease. 4<\/strong> (3): 197\u20139. doi<\/a>:10.1007\/BF01649703<\/a>. PMID<\/a> 2769004<\/a>. S2CID<\/a> 7831833<\/a>.<\/em><\/li>\n\n\n\n
  31. \u00b7  “What I need to know about Crohn’s Disease”<\/a>. www.niddk.nih.gov. Archived from the original<\/a> on November 21, 2015. Retrieved December 11, 2015.<\/em><\/li>\n\n\n\n
  32. \u00b7  Crohn Disease<\/a><\/em> at eMedicine<\/a><\/li>\n\n\n\n
  33. \u00b7  Podolsky DK (August 2002). “Inflammatory bowel disease”<\/a>. The New England Journal of Medicine (Submitted manuscript). 347<\/strong> (6): 417\u201329. doi<\/a>:10.1056\/NEJMra020831<\/a>. PMID<\/a> 12167685<\/a>. Archived<\/a> from the original on April 28, 2021. Retrieved September 4, 2018.<\/em><\/li>\n\n\n\n
  34. \u00b7  Mueller MH, Kreis ME, Gross ML, Becker HD, Zittel TT, Jehle EC (August 2002). “Anorectal functional disorders in the absence of anorectal inflammation in patients with Crohn’s disease”<\/a>. The British Journal of Surgery. 89<\/strong> (8): 1027\u201331. doi<\/a>:10.1046\/j.1365-2168.2002.02173.x<\/a>. PMID<\/a> 12153630<\/a>. S2CID<\/a> 42383375<\/a>.<\/em><\/li>\n\n\n\n
  35. \u00b7  Ingle, Sachin B; Hinge, Chitra R; Dakhure, Sarita; Bhosale, Smita S (May 16, 2013). “Isolated gastric Crohn’s disease”<\/a>. World Journal of Clinical Cases. 1<\/strong> (2): 71\u201373. doi<\/a>:10.12998\/wjcc.v1.i2.71<\/a>. ISSN<\/a> 2307-8960<\/a>. PMC<\/a> 3845940<\/a>. PMID<\/a> 24303469<\/a>.<\/em><\/li>\n\n\n\n
  36. \u00b7  Fix OK, Soto JA, Andrews CW, Farraye FA (December 2004). “Gastroduodenal Crohn’s disease”. Gastrointestinal Endoscopy. 60<\/strong> (6): 985. doi<\/a>:10.1016\/S0016-5107(04)02200-X<\/a>. PMID<\/a> 15605018<\/a>.<\/em><\/li>\n\n\n\n
  37. \u00b7  Antonelli E, Bassotti G, Tramontana M, Hansel K, Stingeni L, Ardizzone S, Genovese G, Marzano AV, Maconi G (January 2021). “Dermatological Manifestations in Inflammatory Bowel Diseases”<\/a>. J Clin Med. 10<\/strong> (2): 364. doi<\/a>:10.3390\/jcm10020364<\/a>. PMC<\/a> 7835974<\/a>. PMID<\/a> 33477990<\/a>.<\/em><\/li>\n\n\n\n
  38. \u00b7  Aberumand, Babak; Howard, Jessica; Howard, John (January 3, 2017). “Metastatic Crohn’s Disease: An Approach to an Uncommon but Important Cutaneous Disorder”<\/a>. BioMed Research International. 2017<\/strong>: e8192150. doi<\/a>:10.1155\/2017\/8192150<\/a>. ISSN<\/a> 2314-6133<\/a>. PMC<\/a> 5239966<\/a>. PMID<\/a> 28127561<\/a>.<\/em><\/li>\n\n\n\n
  39. \u00b7  Beattie RM, Croft NM, Fell JM, Afzal NA, Heuschkel RB (May 2006). “Inflammatory bowel disease”<\/a>. Archives of Disease in Childhood. 91<\/strong> (5): 426\u201332. doi<\/a>:10.1136\/adc.2005.080481<\/a>. PMC<\/a> 2082730<\/a>. PMID<\/a> 16632672<\/a>.<\/em><\/li>\n\n\n\n
  40. \u00b7  B\u00fcller HA (February 1997). “Problems in diagnosis of IBD in children”<\/a>. The Netherlands Journal of Medicine (Submitted manuscript). 50<\/strong> (2): S8\u201311. doi<\/a>:10.1016\/S0300-2977(96)00064-2<\/a>. PMID<\/a> 9050326<\/a>. Archived<\/a> from the original on August 28, 2021. Retrieved September 4, 2018.<\/em><\/li>\n\n\n\n
  41. \u00b7  O’Keefe SJ (1996). “Nutrition and gastrointestinal disease”. Scandinavian Journal of Gastroenterology. Supplement. 220<\/strong>: 52\u20139. doi<\/a>:10.3109\/00365529609094750<\/a>. PMID<\/a> 8898436<\/a>.<\/em><\/li>\n\n\n\n
  42. \u00b7  Harbord M, Annese V, Vavricka SR, Allez M, Barreiro-de Acosta M, Boberg KM, et al. (March 2016). “The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease”<\/a>. Journal of Crohn’s & Colitis. 10<\/strong> (3): 239\u201354. doi<\/a>:10.1093\/ecco-jcc\/jjv213<\/a>. PMC<\/a> 4957476<\/a>. PMID<\/a> 26614685<\/a>.<\/em><\/li>\n\n\n\n
  43. \u00b7  Greenstein AJ, Janowitz HD, Sachar DB (September 1976). “The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients”. Medicine. 55<\/strong> (5): 401\u2013412. doi<\/a>:10.1097\/00005792-197609000-00004<\/a>. PMID<\/a> 957999<\/a>.<\/em><\/li>\n\n\n\n
  44. \u00b7  Bernstein CN, Blanchard JF, Rawsthorne P, Yu N (April 2001). “The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study”. The American Journal of Gastroenterology. 96<\/strong> (4): 1116\u20131122. doi<\/a>:10.1111\/j.1572-0241.2001.03756.x<\/a>. PMID<\/a> 11316157<\/a>.<\/em><\/li>\n\n\n\n
  45. \u00b7  Harbord M, Annese V, Vavricka SR, Allez M, Barreiro-de Acosta M, Boberg KM, et al. (March 2016). “The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease”. Journal of Crohn’s & Colitis. 10<\/strong> (3): 239\u2013254. doi<\/a>:10.1093\/ecco-jcc\/jjv213<\/a>. PMID<\/a> 26614685<\/a>.<\/em><\/li>\n\n\n\n
  46. \u00b7  Trikudanathan G, Venkatesh PG, Navaneethan U (December 2012). “Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease”. Drugs. 72<\/strong> (18): 2333\u201349. doi<\/a>:10.2165\/11638120-000000000-00000<\/a>. PMID<\/a> 23181971<\/a>. S2CID<\/a> 10078879<\/a>.<\/em><\/li>\n\n\n\n
  47. \u00b7  Jose, Folashade A.; Heyman, Melvin B. (February 2008). “Extraintestinal Manifestations of Inflammatory Bowel Disease”<\/a>. Journal of Pediatric Gastroenterology and Nutrition. 46<\/strong> (2): 124\u2013133. doi<\/a>:10.1097\/MPG.0b013e318093f4b0<\/a>. ISSN<\/a> 0277-2116<\/a>. PMC<\/a> 3245880<\/a>. PMID<\/a> 18223370<\/a>.<\/em><\/li>\n\n\n\n
  48. \u00b7  Kumar V, Abbas AK, Fausto N (July 30, 2004). “The Gastrointestinal Tract”. Robbins and Cotran: Pathologic Basis of Disease (7th ed.). Philadelphia, Pennsylvania: Elsevier Saunders. p. 847. ISBN<\/a> 978-0-7216-0187-8<\/a>.<\/em><\/li>\n\n\n\n
  49. \u00b7  Loos, Elke; Lemkens, Peter; Poorten, Vincent Vander; Humblet, Evelien; Laureyns, Griet (January 2019). “Laryngeal Manifestations of Inflammatory Bowel Disease”<\/a>. Journal of Voice. 33<\/strong> (1): 1\u20136. doi<\/a>:10.1016\/j.jvoice.2017.09.021<\/a>. ISSN<\/a> 1873-4588<\/a>. PMID<\/a> 29605161<\/a>. S2CID<\/a> 4565046<\/a>. Archived<\/a> from the original on October 7, 2022. Retrieved September 6, 2021.<\/em><\/li>\n\n\n\n
  50. \u00b7  Hasegawa, Naoko; Ishimoto, Shin-Ichi; Takazoe, Masakazu; Tsunoda, Koichi; Fujimaki, Youko; Shiraishi, Aiko; Kinoshita, Makoto; Okada, Kazunari (July 2009). “Recurrent hoarseness due to inflammatory vocal fold lesions in a patient with Crohn’s disease”<\/a>. The Annals of Otology, Rhinology, and Laryngology. 118<\/strong> (7): 532\u2013535. doi<\/a>:10.1177\/000348940911800713<\/a>. ISSN<\/a> 0003-4894<\/a>. PMID<\/a> 19708494<\/a>. S2CID<\/a> 8472904<\/a>. Archived<\/a> from the original on September 6, 2021. Retrieved September 6, 2021.<\/em><\/li>\n\n\n\n
  51. \u00b7  Li, Cong J.; Aronowitz, Paul (March 2013). “Sore throat, odynophagia, hoarseness, and a muffled, high-pitched voice”<\/a>. Cleveland Clinic Journal of Medicine. 80<\/strong> (3): 144\u2013145. doi<\/a>:10.3949\/ccjm.80a.12056<\/a>. ISSN<\/a> 0891-1150<\/a>. PMID<\/a> 23456463<\/a>. S2CID<\/a> 31002546<\/a>.<\/em><\/li>\n\n\n\n
  52. \u00b7  Lu, De-Gan; Ji, Xiao-Qing; Liu, Xun; Li, Hong-Jia; Zhang, Cai-Qing (January 7, 2014). “Pulmonary manifestations of Crohn’s disease”<\/a>. World Journal of Gastroenterology. 20<\/strong> (1): 133\u2013141. doi<\/a>:10.3748\/wjg.v20.i1.133<\/a>. ISSN<\/a> 1007-9327<\/a>. PMC<\/a> 3886002<\/a>. PMID<\/a> 24415866<\/a>.<\/em><\/li>\n\n\n\n
  53. \u00b7  Bernstein M, Irwin S, Greenberg GR (September 2005). “Maintenance infliximab treatment is associated with improved bone mineral density in Crohn’s disease”. The American Journal of Gastroenterology. 100<\/strong> (9): 2031\u20135. doi<\/a>:10.1111\/j.1572-0241.2005.50219.x<\/a>. PMID<\/a> 16128948<\/a>. S2CID<\/a> 28982700<\/a>.<\/em><\/li>\n\n\n\n
  54. \u00b7  Thrash B, Patel M, Shah KR, Boland CR, Menter A (February 2013). “Cutaneous manifestations of gastrointestinal disease: part II”. Journal of the American Academy of Dermatology. 68<\/strong> (2): 211.e1-33, quiz 244\u20136. doi<\/a>:10.1016\/j.jaad.2012.10.036<\/a>. PMID<\/a> 23317981<\/a>. S2CID<\/a> 1819416<\/a>.<\/em><\/li>\n\n\n\n
  55. \u00b7  Roth N, Biedermann L, Fournier N, Butter M, Vavricka SR, Navarini AA, et al. (2019). “Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study”<\/a>. PLOS ONE. 14<\/strong> (1): e0210436. Bibcode<\/a>:2019PLoSO..1410436R<\/a>. doi<\/a>:10.1371\/journal.pone.0210436<\/a>. PMC<\/a> 6347222<\/a>. PMID<\/a> 30682031<\/a>. S2CID<\/a> 59275029<\/a>.<\/em><\/li>\n\n\n\n
  56. \u00b7  Crohn’s disease<\/a> Archived<\/a> August 5, 2007, at the Wayback Machine<\/a>. professionals.epilepsy.com. Retrieved July 13, 2007.<\/li>\n\n\n\n
  57. \u00b7  “Mental and Emotional Well-Being”<\/a>. Crohn’s & Colitis Foundation. Archived<\/a> from the original on October 7, 2022. Retrieved September 6, 2021.<\/em><\/li>\n\n\n\n
  58. \u00b7  Fracas E, Costantino A, Vecchi M, Buoli M. Depressive and Anxiety Disorders in Patients with Inflammatory Bowel Diseases: Are There Any Gender Differences? International Journal of Environmental Research and Public Health. 2023; 20(13):6255. https:\/\/doi.org\/10.3390\/ijerph20136255<\/a><\/li>\n\n\n\n
  59. \u00b7  Barberio B, Zamani M, Black CJ, Savarino EV, Ford AC. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021 May;6(5):359-370. doi: 10.1016\/S2468-1253(21)00014-5<\/li>\n\n\n\n
  60. \u00b7  Lomer MC (August 2011). “Dietary and nutritional considerations for inflammatory bowel disease”<\/a>. The Proceedings of the Nutrition Society. 70<\/strong> (3): 329\u201335. doi<\/a>:10.1017\/S0029665111000097<\/a>. PMID<\/a> 21450124<\/a>.<\/em><\/li>\n\n\n\n
  61. \u00b7  Gerasimidis K, McGrogan P, Edwards CA (August 2011). “The aetiology and impact of malnutrition in paediatric inflammatory bowel disease”<\/a>. Journal of Human Nutrition and Dietetics (Review). 24<\/strong> (4): 313\u201326. doi<\/a>:10.1111\/j.1365-277X.2011.01171.x<\/a>. PMID<\/a> 21564345<\/a>.<\/em><\/li>\n\n\n\n
  62. \u00b7  MedlinePlus Encyclopedia<\/a><\/em>: Small bowel bacterial overgrowth<\/a><\/li>\n\n\n\n
  63. \u00b7  Klaus, Jochen; Spaniol, Ulrike; Adler, Guido; Mason, Richard A.; Reinshagen, Max; von Tirpitz C, Christian (July 30, 2009). “Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn’s Disease”<\/a>. BMC Gastroenterology. 9<\/strong> (1): 61. doi<\/a>:10.1186\/1471-230X-9-61<\/a>. ISSN<\/a> 1471-230X<\/a>. PMC<\/a> 2728727<\/a>. PMID<\/a> 19643023<\/a>.<\/em> <\/a>Text was copied from this source, which is available under a Creative Commons Attribution 2.0 Generic (CC BY 2.0)<\/a> Archived<\/a> February 23, 2011, at the Wayback Machine<\/a> license.<\/li>\n\n\n\n
  64. \u00b7  “Intestinal Obstruction”<\/a>. MERCK MANUAL Consumer Version. Archived<\/a> from the original on July 10, 2016. Retrieved June 27, 2016.<\/em><\/li>\n\n\n\n
  65. \u00b7  “Anorectal Fistula”<\/a>. MERCK MANUAL Consumer Version. Archived<\/a> from the original on July 10, 2016. Retrieved June 27, 2016.<\/em><\/li>\n\n\n\n
  66. \u00b7  “Anorectal Abscess”<\/a>. MERCK MANUAL Consumer Version. Archived<\/a> from the original on June 14, 2016. Retrieved June 27, 2016.<\/em><\/li>\n\n\n\n
  67. \u00b7  Enterovesical Fistula<\/a><\/em> at eMedicine<\/a><\/li>\n\n\n\n
  68. \u00b7  Moln\u00e1r, Tam\u00e1s; Tiszlavicz, L\u00e1szl\u00f3; Gyulai, Csaba; Nagy, Ferenc; Lonovics, J\u00e1nos (May 28, 2005). “Clinical significance of granuloma in Crohn’s disease”<\/a>. World Journal of Gastroenterology. 11<\/strong> (20): 3118\u20133121. doi<\/a>:10.3748\/wjg.v11.i20.3118<\/a>. ISSN<\/a> 1007-9327<\/a>. PMC<\/a> 4305850<\/a>. PMID<\/a> 15918200<\/a>.<\/em><\/li>\n\n\n\n
  69. \u00b7  Bye WA, Nguyen TM, Parker CE, Jairath V, East JE (September 2017). “Strategies for detecting colon cancer in patients with inflammatory bowel disease”<\/a>. The Cochrane Database of Systematic Reviews. 2017<\/strong> (9): CD000279. doi<\/a>:10.1002\/14651858.CD000279.pub4<\/a>. PMC<\/a> 6483622<\/a>. PMID<\/a> 28922695<\/a>.<\/em><\/li>\n\n\n\n
  70. \u00b7  Ekbom A, Helmick C, Zack M, Adami HO (August 1990). “Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement”<\/a>. Lancet. 336<\/strong> (8711): 357\u20139. doi<\/a>:10.1016\/0140-6736(90)91889-I<\/a>. PMID<\/a> 1975343<\/a>. S2CID<\/a> 2046255<\/a>. Archived<\/a> from the original on August 5, 2020. Retrieved September 4, 2018.<\/em><\/li>\n\n\n\n
  71. \u00b7  Itzkowitz SH, Present DH, et al. (Crohn’s and Colitis Foundation of America Colon Cancer in IBD Study Group) (March 2005). “Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease”. Inflammatory Bowel Diseases. 11<\/strong> (3): 314\u201321. doi<\/a>:10.1097\/01.mib.0000160811.76729.d5<\/a>. PMID<\/a> 15735438<\/a>.<\/em><\/li>\n\n\n\n
  72. \u00b7  Zisman TL, Rubin DT (May 2008). “Colorectal cancer and dysplasia in inflammatory bowel disease”<\/a>. World Journal of Gastroenterology. 14<\/strong> (17): 2662\u20139. doi<\/a>:10.3748\/wjg.14.2662<\/a>. PMC<\/a> 2709054<\/a>. PMID<\/a> 18461651<\/a>.<\/em><\/li>\n\n\n\n
  73. \u00b7  Axelrad JE, Lichtiger S, Yajnik V (May 2016). “Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment”<\/a>. World Journal of Gastroenterology (Review). 22<\/strong> (20): 4794\u2013801. doi<\/a>:10.3748\/wjg.v22.i20.4794<\/a>. PMC<\/a> 4873872<\/a>. PMID<\/a> 27239106<\/a>.<\/em><\/li>\n\n\n\n
  74. \u00b7  Parakkal, Deepak; Sifuentes, Humberto; Semer, Rumi; Ehrenpreis, Eli Daniel (November 2011). “Hepatosplenic T-cell lymphoma in patients receiving TNF-\u03b1 inhibitor therapy: expanding the groups at risk”<\/a>. European Journal of Gastroenterology & Hepatology. 23<\/strong> (12): 1150\u20131156. doi<\/a>:10.1097\/MEG.0b013e32834bb90a<\/a>. ISSN<\/a> 1473-5687<\/a>. PMID<\/a> 21941193<\/a>. S2CID<\/a> 27267004<\/a>. Archived<\/a> from the original on October 3, 2021. Retrieved October 3, 2021.<\/em><\/li>\n\n\n\n
  75. \u00b7  Carrillo M (September 1, 1985). “Man of Many Problems Comes to City for Help”<\/a>. Richmond Times-Dispatch. Richmond, Virginia, USA. p. B1.<\/em><\/li>\n\n\n\n
  76. \u00b7  “Kay, Laura Lynn”<\/a>. Richmond Times-Dispatch. Richmond, Virginia, USA. April 3, 2014.<\/em><\/li>\n\n\n\n
  77. Loebenberg P (March 2, 2014). “Doris L. Johnson, 82, of Westminster”<\/a>. Carroll County Times. Westminster, Maryland, USA.<\/em><\/li>\n\n\n\n
  78. Berrier Jr R (December 31, 2013). “In memoriam: Dan Hodges Jr”<\/a>. The Roanoke Times. Roanoke, Virginia, USA.<\/em><\/li>\n\n\n\n
  79. “Cynthia Meredith Routt”<\/a>. Daily Press. Newport News, Virginia, USA. May 4, 2014. p. A11.<\/em><\/li>\n\n\n\n
  80. \u00b7  Evans JP, Steinhart AH, Cohen Z, McLeod RS (2003). “Home total parenteral nutrition: an alternative to early surgery for complicated inflammatory bowel disease”. Journal of Gastrointestinal Surgery. 7<\/strong> (4): 562\u2013566. doi<\/a>:10.1016\/S1091-255X(02)00132-4<\/a>. PMID<\/a> 12763417<\/a>. S2CID<\/a> 195305419<\/a>.<\/em><\/li>\n\n\n\n
  81. \u00b7  Kaplan C (October 21, 2005). “IBD and Pregnancy: What You Need to Know”<\/a>. Crohn’s and Colitis Foundation of America<\/a>. Archived from the original<\/a> on February 17, 2012. Retrieved November 7, 2009.<\/em><\/li>\n\n\n\n
  82. \u00b7  Rodrigues, Francielle Profeta; Novaes, Jane Andrea Vieira; Pinheiro, Marcela Monteiro; Martins, Paula; Cunha-Melo, Jos\u00e9 Renan (October 23, 2019). Intestinal Ostomy Complications and Care<\/a>. IntechOpen. ISBN<\/a> 978-1-78984-186-2<\/a>. Archived<\/a> from the original on October 7, 2022. Retrieved September 6, 2021.<\/em><\/li>\n\n\n\n
  83. \u00b7  “Definition of Autoimmunity & Autoimmune Disease – Autoimmune Disease | Johns Hopkins Pathology”<\/a>. pathology.jhu.edu. Archived<\/a> from the original on October 3, 2021. Retrieved October 3, 2021.<\/em><\/li>\n\n\n\n
  84. \u00b7  Ciccarelli, F.; Martinis, M. De; Ginaldi, L. (January 2013). “An Update on Autoinflammatory Diseases”<\/a>. Current Medicinal Chemistry. 21<\/strong> (3): 261\u2013269. doi<\/a>:10.2174\/09298673113206660303<\/a>. ISSN<\/a> 0929-8673<\/a>. PMC<\/a> 3905709<\/a>. PMID<\/a> 24164192<\/a>.<\/em><\/li>\n\n\n\n
  85. \u00b7  Li, Na; Shi, Rui-Hua (January 7, 2018). “Updated review on immune factors in pathogenesis of Crohn’s disease”<\/a>. World Journal of Gastroenterology. 24<\/strong> (1): 15\u201322. doi<\/a>:10.3748\/wjg.v24.i1.15<\/a>. ISSN<\/a> 1007-9327<\/a>. PMC<\/a> 5757119<\/a>. PMID<\/a> 29358878<\/a>.<\/em><\/li>\n\n\n\n
  86. \u00b7  Roggenbuck, D.; Reinhold, D.; Baumgart, D. C.; Schierack, P.; Conrad, K.; Laass, M. W. (January 1, 2016), Makowski, Gregory S. (ed.), “Chapter Two – Autoimmunity in Crohn’s Disease\u2014A Putative Stratification Factor of the Clinical Phenotype”<\/a>, Advances in Clinical Chemistry, Elsevier, 77<\/strong>: 77\u2013101, doi<\/a>:10.1016\/bs.acc.2016.06.002<\/a>, PMID<\/a> 27717419<\/a>, retrieved November 4, 2021<\/em><\/li>\n\n\n\n
  87. \u00b7  Marks, Daniel J. B.; Rahman, Farooq Z.; Sewell, Gavin W.; Segal, Anthony W. (February 2010). “Crohn’s Disease: an Immune Deficiency State”<\/a>. Clinical Reviews in Allergy & Immunology. 38<\/strong> (1): 20\u201331. doi<\/a>:10.1007\/s12016-009-8133-2<\/a>. ISSN<\/a> 1080-0549<\/a>. PMC<\/a> 4568313<\/a>. PMID<\/a> 19437144<\/a>.<\/em><\/li>\n\n\n\n
  88. \u00b7  Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD (March 2019). “ACG Clinical Guideline: Ulcerative Colitis in Adults”<\/a>. The American Journal of Gastroenterology. 114<\/strong> (3): 384\u2013413. doi<\/a>:10.14309\/ajg.0000000000000152<\/a>. PMID<\/a> 30840605<\/a>. S2CID<\/a> 73473272<\/a>.<\/em><\/li>\n\n\n\n
  89. \u00b7  Nachimuthu S. “Crohn’s disease”<\/a>. eMedicineHealth. Archived<\/a> from the original on December 9, 2019. Retrieved December 8, 2019.<\/em><\/li>\n\n\n\n
  90. \u00b7  Braat H, Peppelenbosch MP, Hommes DW (August 2006). “Immunology of Crohn’s disease”. Annals of the New York Academy of Sciences. 1072<\/strong> (1): 135\u201354. Bibcode<\/a>:2006NYASA1072..135B<\/a>. doi<\/a>:10.1196\/annals.1326.039<\/a>. PMID<\/a> 17057196<\/a>. S2CID<\/a> 2627465<\/a>.<\/em><\/li>\n\n\n\n
  91. \u00b7  Henckaerts L, Figueroa C, Vermeire S, Sans M (May 2008). “The role of genetics in inflammatory bowel disease”. Current Drug Targets. 9<\/strong> (5): 361\u20138. doi<\/a>:10.2174\/138945008784221161<\/a>. PMID<\/a> 18473763<\/a>.<\/em><\/li>\n\n\n\n
  92. \u00b7  Marks DJ, Harbord MW, MacAllister R, Rahman FZ, Young J, Al-Lazikani B, Lees W, Novelli M, Bloom S, Segal AW (February 2006). “Defective acute inflammation in Crohn’s disease: a clinical investigation”. Lancet. 367<\/strong> (9511): 668\u201378. doi<\/a>:10.1016\/S0140-6736(06)68265-2<\/a>. PMID<\/a> 16503465<\/a>. S2CID<\/a> 13898663<\/a>.<\/em><\/li>\n\n\n\n
  93. \u00b7  Comalada M, Peppelenbosch MP (September 2006). “Impaired innate immunity in Crohn’s disease”. Trends in Molecular Medicine. 12<\/strong> (9): 397\u20139. doi<\/a>:10.1016\/j.molmed.2006.07.005<\/a>. PMID<\/a> 16890491<\/a>.<\/em><\/li>\n\n\n\n
  94. \u00b7  Nakagome S, Mano S, Kozlowski L, Bujnicki JM, Shibata H, Fukumaki Y, et al. (June 2012). “Crohn’s disease risk alleles on the NOD2 locus have been maintained by natural selection on standing variation”<\/a>. Molecular Biology and Evolution. 29<\/strong> (6): 1569\u201385. doi<\/a>:10.1093\/molbev\/mss006<\/a>. PMC<\/a> 3697811<\/a>. PMID<\/a> 22319155<\/a>.<\/em><\/li>\n\n\n\n
  95. \u00b7  “Crohn’s disease has strong genetic link: study”<\/a>. Crohn’s and Colitis Foundation of America<\/a>. April 16, 2007. Archived from the original<\/a> on May 2, 2007. Retrieved November 7, 2009.<\/em><\/li>\n\n\n\n
  96. \u00b7  Liu JZ, Anderson CA (June 2014). “Genetic studies of Crohn’s disease: past, present and future”<\/a>. Best Practice & Research. Clinical Gastroenterology. 28<\/strong> (3): 373\u201386. doi<\/a>:10.1016\/j.bpg.2014.04.009<\/a>. PMC<\/a> 4075408<\/a>. PMID<\/a> 24913378<\/a>.<\/em><\/li>\n\n\n\n
  97. \u00b7  Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. (May 2001). “A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease”. Nature. 411<\/strong> (6837): 603\u20136. Bibcode<\/a>:2001Natur.411..603O<\/a>. doi<\/a>:10.1038\/35079114<\/a>. hdl<\/a>:2027.42\/62856<\/a>. PMID<\/a> 11385577<\/a>. S2CID<\/a> 205017657<\/a>.<\/em><\/li>\n\n\n\n
  98. \u00b7  Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJ, et al. (April 2002). “The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease”. Gastroenterology. 122<\/strong> (4): 867\u201374. doi<\/a>:10.1053\/gast.2002.32415<\/a>. PMID<\/a> 11910337<\/a>.<\/em><\/li>\n\n\n\n
  99. \u00b7  Kaser A, Lee AH, Franke A, Glickman JN, Zeissig S, Tilg H, et al. (September 2008). “XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease”<\/a>. Cell. 134<\/strong> (5): 743\u201356. doi<\/a>:10.1016\/j.cell.2008.07.021<\/a>. PMC<\/a> 2586148<\/a>. PMID<\/a> 18775308<\/a>.<\/em><\/li>\n\n\n\n
  100. \u00b7  Clevers H (February 2009). “Inflammatory bowel disease, stress, and the endoplasmic reticulum”. The New England Journal of Medicine. 360<\/strong> (7): 726\u20137. doi<\/a>:10.1056\/NEJMcibr0809591<\/a>. PMID<\/a> 19213688<\/a>.<\/em><\/li>\n\n\n\n
  101. \u00b7  Vermeire S (June 2004). “NOD2\/CARD15: relevance in clinical practice”. Best Practice & Research. Clinical Gastroenterology (Review). 18<\/strong> (3): 569\u201375. doi<\/a>:10.1016\/j.bpg.2003.12.008<\/a>. PMID<\/a> 15157828<\/a>.<\/em><\/li>\n\n\n\n
  102. \u00b7  Prescott NJ, Fisher SA, Franke A, Hampe J, Onnie CM, Soars D, et al. (May 2007). “A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn’s disease and is independent of CARD15 and IBD5”<\/a>. Gastroenterology. 132<\/strong> (5): 1665\u201371. doi<\/a>:10.1053\/j.gastro.2007.03.034<\/a>. PMID<\/a> 17484864<\/a>.<\/em><\/li>\n\n\n\n
  103. \u00b7  Diegelmann J, Czamara D, Le Bras E, Zimmermann E, Olszak T, Bedynek A, et al. (2013). “Intestinal DMBT1 expression is modulated by Crohn’s disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2”<\/a>. PLOS ONE. 8<\/strong> (11): e77773. Bibcode<\/a>:2013PLoSO…877773D<\/a>. doi<\/a>:10.1371\/journal.pone.0077773<\/a>. PMC<\/a> 3818382<\/a>. PMID<\/a> 24223725<\/a>.<\/em><\/li>\n\n\n\n
  104. \u00b7  Prescott NJ, Dominy KM, Kubo M, Lewis CM, Fisher SA, Redon R, et al. (May 2010). “Independent and population-specific association of risk variants at the IRGM locus with Crohn’s disease”<\/a>. Human Molecular Genetics. 19<\/strong> (9): 1828\u201339. doi<\/a>:10.1093\/hmg\/ddq041<\/a>. PMC<\/a> 2850616<\/a>. PMID<\/a> 20106866<\/a>.<\/em><\/li>\n\n\n\n
  105. \u00b7  Chermesh I, Azriel A, Alter-Koltunoff M, Eliakim R, Karban A, Levi BZ (July 2007). “Crohn’s disease and SLC11A1 promoter polymorphism”. Digestive Diseases and Sciences. 52<\/strong> (7): 1632\u20135. doi<\/a>:10.1007\/s10620-006-9682-3<\/a>. PMID<\/a> 17385031<\/a>. S2CID<\/a> 11429585<\/a>.<\/em><\/li>\n\n\n\n
  106. \u00b7  Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. (November 2012). “Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease”<\/a>. Nature. 491<\/strong> (7422): 119\u201324. Bibcode<\/a>:2012Natur.491..119.<\/a>. doi<\/a>:10.1038\/nature11582<\/a>. PMC<\/a> 3491803<\/a>. PMID<\/a> 23128233<\/a>.<\/em><\/li>\n\n\n\n
  107. \u00b7  Walker MM, Murray JA (August 2011). “An update in the diagnosis of coeliac disease”. Histopathology (Review). 59<\/strong> (2): 166\u201379. doi<\/a>:10.1111\/j.1365-2559.2010.03680.x<\/a>. PMID<\/a> 21054494<\/a>. S2CID<\/a> 5196629<\/a>. Recent genome-wide association studies have shown that chronic inflammatory and autoimmune diseases are linked genetically to coeliac disease; for example, type 1 diabetes mellitus, Grave’s disease and Crohn’s disease.<\/em><\/li>\n\n\n\n
  108. \u00b7  Coghlan A (January 10, 2018). “A single gene can either raise or lower Crohn’s disease risk”<\/a>. New Scientist. Archived<\/a> from the original on November 9, 2020. Retrieved November 5, 2020.<\/em><\/li>\n\n\n\n
  109. \u00b7  Marks DJ, Segal AW (January 2008). “Innate immunity in inflammatory bowel disease: a disease hypothesis”<\/a>. The Journal of Pathology. 214<\/strong> (2): 260\u20136. doi<\/a>:10.1002\/path.2291<\/a>. PMC<\/a> 2635948<\/a>. PMID<\/a> 18161747<\/a>.<\/em><\/li>\n\n\n\n
  110. \u00b7  Cobrin GM, Abreu MT (August 2005). “Defects in mucosal immunity leading to Crohn’s disease”. Immunological Reviews. 206<\/strong> (1): 277\u201395. doi<\/a>:10.1111\/j.0105-2896.2005.00293.x<\/a>. PMID<\/a> 16048555<\/a>. S2CID<\/a> 37353838<\/a>.<\/em><\/li>\n\n\n\n
  111. \u00b7  Elson CO, Cong Y, Weaver CT, Schoeb TR, McClanahan TK, Fick RB, Kastelein RA (June 2007). “Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice”. Gastroenterology. 132<\/strong> (7): 2359\u201370. doi<\/a>:10.1053\/j.gastro.2007.03.104<\/a>. PMID<\/a> 17570211<\/a>.<\/em><\/li>\n\n\n\n
  112. \u00b7  Velasquez-Manoff M (June 29, 2008). “The Worm Turns”<\/a>. The New York Times<\/a>. Archived<\/a> from the original on January 7, 2017.<\/em><\/li>\n\n\n\n
  113. \u00b7  Sartor RB (July 2006). “Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis”. Nature Clinical Practice. Gastroenterology & Hepatology. 3<\/strong> (7): 390\u2013407. doi<\/a>:10.1038\/ncpgasthep0528<\/a>. PMID<\/a> 16819502<\/a>. S2CID<\/a> 3329677<\/a>.<\/em><\/li>\n\n\n\n
  114. \u00b7  Dogan B, Scherl E, Bosworth B, Yantiss R, Altier C, McDonough PL, Jiang ZD, Dupont HL, Garneau P, Harel J, Rishniw M, Simpson KW (January 2013). “Multidrug resistance is common in Escherichia coli associated with ileal Crohn’s disease”<\/a>. Inflammatory Bowel Diseases. 19<\/strong> (1): 141\u201350. doi<\/a>:10.1002\/ibd.22971<\/a>. PMID<\/a> 22508665<\/a>. S2CID<\/a> 25518704<\/a>.<\/em><\/li>\n\n\n\n
  115. \u00b7  Subramanian S, Roberts CL, Hart CA, Martin HM, Edwards SW, Rhodes JM, Campbell BJ (February 2008). “Replication of Colonic Crohn’s Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics”<\/a>. Antimicrobial Agents and Chemotherapy. 52<\/strong> (2): 427\u201334. doi<\/a>:10.1128\/AAC.00375-07<\/a>. PMC<\/a> 2224732<\/a>. PMID<\/a> 18070962<\/a>.<\/em><\/li>\n\n\n\n
  116. \u00b7  Mpofu CM, Campbell BJ, Subramanian S, Marshall-Clarke S, Hart CA, Cross A, Roberts CL, McGoldrick A, Edwards SW, Rhodes JM (November 2007). “Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn’s disease”<\/a> (PDF). Gastroenterology. 133<\/strong> (5): 1487\u201398. doi<\/a>:10.1053\/j.gastro.2007.08.004<\/a>. PMID<\/a> 17919633<\/a>.<\/em><\/li>\n\n\n\n
  117. \u00b7  Naser SA, Collins MT (December 2005). “Debate on the lack of evidence of Mycobacterium avium subsp. paratuberculosis in Crohn’s disease”<\/a>. Inflammatory Bowel Diseases. 11<\/strong> (12): 1123. doi<\/a>:10.1097\/01.MIB.0000191609.20713.ea<\/a>. PMID<\/a> 16306778<\/a>.<\/em><\/li>\n\n\n\n
  118. \u00b7  Naser SA, Sagramsingh SR, Naser AS, Thanigachalam S (June 2014). “Mycobacterium avium subspecies paratuberculosis causes Crohn’s disease in some inflammatory bowel disease patients”<\/a>. World Journal of Gastroenterology. 20<\/strong> (23): 7403\u201315. doi<\/a>:10.3748\/wjg.v20.i23.7403<\/a>. PMC<\/a> 4064085<\/a>. PMID<\/a> 24966610<\/a>.<\/em><\/li>\n\n\n\n
  119. \u00b7  “New insights into Crohn’s Disease”<\/a>. Archived from the original<\/a> on September 23, 2013.<\/em><\/li>\n\n\n\n
  120. \u00b7  Glubb DM, Gearry RB, Barclay ML, Roberts RL, Pearson J, Keenan JI, et al. (June 2011). “NOD2 and ATG16L1 polymorphisms affect monocyte responses in Crohn’s disease”<\/a>. World Journal of Gastroenterology. 17<\/strong> (23): 2829\u201337. doi<\/a>:10.3748\/wjg.v17.i23.2829<\/a> (inactive August 1, 2023). PMC<\/a> 3120942<\/a>. PMID<\/a> 21734790<\/a>.<\/em><\/li>\n\n\n\n
  121. \u00b7  Clancy R, Ren Z, Turton J, Pang G, Wettstein A (May 2007). “Molecular evidence for Mycobacterium avium subspecies paratuberculosis (MAP) in Crohn’s disease correlates with enhanced TNF-alpha secretion”. Digestive and Liver Disease. 39<\/strong> (5): 445\u201351. doi<\/a>:10.1016\/j.dld.2006.12.006<\/a>. PMID<\/a> 17317344<\/a>.<\/em><\/li>\n\n\n\n
  122. \u00b7  Nakase H, Tamaki H, Matsuura M, Chiba T, Okazaki K (November 2011). “Involvement of mycobacterium avium subspecies paratuberculosis in TNF-\u03b1 production from macrophage: possible link between MAP and immune response in Crohn’s disease”. Inflammatory Bowel Diseases. 17<\/strong> (11): E140\u20132. doi<\/a>:10.1002\/ibd.21750<\/a>. PMID<\/a> 21990211<\/a>.<\/em><\/li>\n\n\n\n
  123. \u00b7  Baumgart M, Dogan B, Rishniw M, Weitzman G, Bosworth B, Yantiss R, et al. (September 2007). “Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn’s disease involving the ileum”<\/a>. The ISME Journal. 1<\/strong> (5): 403\u201318. Bibcode<\/a>:2007ISMEJ…1..403B<\/a>. doi<\/a>:10.1038\/ismej.2007.52<\/a>. PMID<\/a> 18043660<\/a>.<\/em><\/li>\n\n\n\n
  124. \u00b7  Sasaki M, Sitaraman SV, Babbin BA, Gerner-Smidt P, Ribot EM, Garrett N, Alpern JA, Akyildiz A, Theiss AL, Nusrat A, Klapproth JM (October 2007). “Invasive Escherichia coli are a feature of Crohn’s disease”<\/a>. Laboratory Investigation; A Journal of Technical Methods and Pathology. 87<\/strong> (10): 1042\u201354. doi<\/a>:10.1038\/labinvest.3700661<\/a>. PMID<\/a> 17660846<\/a>.<\/em><\/li>\n\n\n\n
  125. \u00b7  Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, Bringer MA, Swidsinski A, Beaugerie L, Colombel JF (August 2004). “High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease”<\/a>. Gastroenterology. 127<\/strong> (2): 412\u201321. doi<\/a>:10.1053\/j.gastro.2004.04.061<\/a>. PMID<\/a> 15300573<\/a>.<\/em><\/li>\n\n\n\n
  126. \u00b7  Nickerson KP, McDonald C (2012). Mizoguchi E (ed.). “Crohn’s disease-associated adherent-invasive Escherichia coli adhesion is enhanced by exposure to the ubiquitous dietary polysaccharide maltodextrin”<\/a>. PLOS ONE. 7<\/strong> (12): e52132. Bibcode<\/a>:2012PLoSO…752132N<\/a>. doi<\/a>:10.1371\/journal.pone.0052132<\/a>. PMC<\/a> 3520894<\/a>. PMID<\/a> 23251695<\/a>.<\/em><\/li>\n\n\n\n
  127. \u00b7  Martinez-Medina M, Naves P, Blanco J, Aldeguer X, Blanco JE, Blanco M, Ponte C, Soriano F, Darfeuille-Michaud A, Garcia-Gil LJ (September 2009). “Biofilm formation as a novel phenotypic feature of adherent-invasive Escherichia coli (AIEC)”<\/a>. BMC Microbiology. 9<\/strong> (1): 202. doi<\/a>:10.1186\/1471-2180-9-202<\/a>. PMC<\/a> 2759958<\/a>. PMID<\/a> 19772580<\/a>.<\/em><\/li>\n\n\n\n
  128. \u00b7  Chargui A, Cesaro A, Mimouna S, Fareh M, Brest P, Naquet P, Darfeuille-Michaud A, H\u00e9buterne X, Mograbi B, Vouret-Craviari V, Hofman P (2012). “Subversion of autophagy in adherent invasive Escherichia coli-infected neutrophils induces inflammation and cell death”<\/a>. PLOS ONE. 7<\/strong> (12): e51727. Bibcode<\/a>:2012PLoSO…751727C<\/a>. doi<\/a>:10.1371\/journal.pone.0051727<\/a>. PMC<\/a> 3522719<\/a>. PMID<\/a> 23272151<\/a>.<\/em><\/li>\n\n\n\n
  129. \u00b7  Craven M, Egan CE, Dowd SE, McDonough SP, Dogan B, Denkers EY, Bowman D, Scherl EJ, Simpson KW (2012). “Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn’s disease”<\/a>. PLOS ONE. 7<\/strong> (7): e41594. Bibcode<\/a>:2012PLoSO…741594C<\/a>. doi<\/a>:10.1371\/journal.pone.0041594<\/a>. PMC<\/a> 3404971<\/a>. PMID<\/a> 22848538<\/a>.<\/em><\/li>\n\n\n\n
  130. \u00b7  Barnich N, Darfeuille-Michaud A (January 2007). “Adherent-invasive Escherichia coli and Crohn’s disease”. Current Opinion in Gastroenterology. 23<\/strong> (1): 16\u201320. doi<\/a>:10.1097\/MOG.0b013e3280105a38<\/a>. PMID<\/a> 17133079<\/a>. S2CID<\/a> 23564986<\/a>.<\/em><\/li>\n\n\n\n
  131. \u00b7  Cenac N, Andrews CN, Holzhausen M, Chapman K, Cottrell G, Andrade-Gordon P, Steinhoff M, Barbara G, Beck P, Bunnett NW, Sharkey KA, Ferraz JG, Shaffer E, Vergnolle N (March 2007). “Role for protease activity in visceral pain in irritable bowel syndrome”<\/a>. The Journal of Clinical Investigation. 117<\/strong> (3): 636\u201347. doi<\/a>:10.1172\/JCI29255<\/a>. PMC<\/a> 1794118<\/a>. PMID<\/a> 17304351<\/a>.<\/em><\/li>\n\n\n\n
  132. \u00b7  Cenac N, Coelho AM, Nguyen C, Compton S, Andrade-Gordon P, MacNaughton WK, Wallace JL, Hollenberg MD, Bunnett NW, Garcia-Villar R, Bueno L, Vergnolle N (November 2002). “Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2”<\/a>. The American Journal of Pathology. 161<\/strong> (5): 1903\u201315. doi<\/a>:10.1016\/S0002-9440(10)64466-5<\/a>. PMC<\/a> 1850779<\/a>. PMID<\/a> 12414536<\/a>.<\/em><\/li>\n\n\n\n
  133. \u00b7  Boorom KF, Smith H, Nimri L, Viscogliosi E, Spanakos G, Parkar U, Li LH, Zhou XN, Ok UZ, Leelayoova S, Jones MS (October 2008). “Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection”<\/a>. Parasites & Vectors. 1<\/strong> (1): 40. doi<\/a>:10.1186\/1756-3305-1-40<\/a>. PMC<\/a> 2627840<\/a>. PMID<\/a> 18937874<\/a>.<\/em><\/li>\n\n\n\n
  134. \u00b7  Hugot JP, Alberti C, Berrebi D, Bingen E, C\u00e9zard JP (December 2003). “Crohn’s disease: the cold chain hypothesis”. Lancet. 362<\/strong> (9400): 2012\u20135. doi<\/a>:10.1016\/S0140-6736(03)15024-6<\/a>. PMID<\/a> 14683664<\/a>. S2CID<\/a> 10254395<\/a>.<\/em><\/li>\n\n\n\n
  135. \u00b7  “Fridges blamed for Crohn’s disease rise”<\/a>. Medical News Today. December 12, 2003. Archived<\/a> from the original on January 3, 2009.<\/em><\/li>\n\n\n\n
  136. \u00b7  Forbes A, Kalantzis T (July 2006). “Crohn’s disease: the cold chain hypothesis”. International Journal of Colorectal Disease. 21<\/strong> (5): 399\u2013401. doi<\/a>:10.1007\/s00384-005-0003-7<\/a>. PMID<\/a> 16059694<\/a>. S2CID<\/a> 13271176<\/a>.<\/em><\/li>\n\n\n\n
  137. \u00b7  Kumamoto CA (August 2011). “Inflammation and gastrointestinal Candida colonization”<\/a>. Current Opinion in Microbiology. 14<\/strong> (4): 386\u201391. doi<\/a>:10.1016\/j.mib.2011.07.015<\/a>. PMC<\/a> 3163673<\/a>. PMID<\/a> 21802979<\/a>.<\/em><\/li>\n\n\n\n
  138. \u00b7  “Possible links between Crohn’s disease and Paratuberculosis”<\/a> (PDF). European Commission Directorate-General Health & Consumer Protection. Archived from the original<\/a> (PDF) on December 17, 2008. Retrieved November 7, 2009.<\/em><\/li>\n\n\n\n
  139. \u00b7  Gui GP, Thomas PR, Tizard ML, Lake J, Sanderson JD, Hermon-Taylor J (March 1997). “Two-year-outcomes analysis of Crohn’s disease treated with rifabutin and macrolide antibiotics”<\/a>. The Journal of Antimicrobial Chemotherapy. 39<\/strong> (3): 393\u2013400. doi<\/a>:10.1093\/jac\/39.3.393<\/a>. PMID<\/a> 9096189<\/a>.<\/em><\/li>\n\n\n\n
  140. \u00b7  Shoda R, Matsueda K, Yamato S, Umeda N (May 1996). “Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan”<\/a>. The American Journal of Clinical Nutrition. 63<\/strong> (5): 741\u20135. doi<\/a>:10.1093\/ajcn\/63.5.741<\/a>. PMID<\/a> 8615358<\/a>.<\/em><\/li>\n\n\n\n
  141. \u00b7  Lesko SM, Kaufman DW, Rosenberg L, Helmrich SP, Miller DR, Stolley PD, Shapiro S (November 1985). “Evidence for an increased risk of Crohn’s disease in oral contraceptive users”. Gastroenterology. 89<\/strong> (5): 1046\u20139. doi<\/a>:10.1016\/0016-5085(85)90207-0<\/a>. PMID<\/a> 4043662<\/a>.<\/em><\/li>\n\n\n\n
  142. \u00b7  Reddy D, Siegel CA, Sands BE, Kane S (July 2006). “Possible association between isotretinoin and inflammatory bowel disease”. The American Journal of Gastroenterology. 101<\/strong> (7): 1569\u201373. doi<\/a>:10.1111\/j.1572-0241.2006.00632.x<\/a>. PMID<\/a> 16863562<\/a>. S2CID<\/a> 27663573<\/a>.<\/em><\/li>\n\n\n\n
  143. \u00b7  Borobio E, Ar\u00edn A, Valcayo A, I\u00f1arrairaegui M, Nantes O, Prieto C (2004). “[Isotretinoin and ulcerous colitis]”<\/a>. Anales del Sistema Sanitario de Navarra (in Spanish). 27<\/strong> (2): 241\u20133. doi<\/a>:10.4321\/S1137-66272004000300009<\/a>. PMID<\/a> 15381956<\/a>.<\/em><\/li>\n\n\n\n
  144. \u00b7  Reniers DE, Howard JM (October 2001). “Isotretinoin-induced inflammatory bowel disease in an adolescent”<\/a>. The Annals of Pharmacotherapy. 35<\/strong> (10): 1214\u20136. doi<\/a>:10.1345\/aph.10368<\/a>. PMID<\/a> 11675849<\/a>. S2CID<\/a> 22216642<\/a>. Archived from the original<\/a> on June 29, 2012. Retrieved November 1, 2010.<\/em><\/li>\n\n\n\n
  145. \u00b7  Segerstrom, Suzanne C.; Miller, Gregory E. (July 2004). “Psychological Stress and the Human Immune System: A Meta-Analytic Study of 30 Years of Inquiry”<\/a>. Psychological Bulletin. 130<\/strong> (4): 601\u2013630. doi<\/a>:10.1037\/0033-2909.130.4.601<\/a>. ISSN<\/a> 0033-2909<\/a>. PMC<\/a> 1361287<\/a>. PMID<\/a> 15250815<\/a>.<\/em><\/li>\n\n\n\n
  146. \u00b7  Lomer MC, Hutchinson C, Volkert S, Greenfield SM, Catterall A, Thompson RP, Powell JJ (December 2004). “Dietary sources of inorganic microparticles and their intake in healthy subjects and patients with Crohn’s disease”<\/a>. The British Journal of Nutrition. 92<\/strong> (6): 947\u201355. doi<\/a>:10.1079\/bjn20041276<\/a>. PMID<\/a> 15613257<\/a>.<\/em><\/li>\n\n\n\n
  147. \u00b7  Powell JJ, Thoree V, Pele LC (October 2007). “Dietary microparticles and their impact on tolerance and immune responsiveness of the gastrointestinal tract”<\/a>. The British Journal of Nutrition. 98<\/strong> (Suppl 1): S59\u201363. doi<\/a>:10.1017\/S0007114507832922<\/a>. PMC<\/a> 2737314<\/a>. PMID<\/a> 17922962<\/a>.<\/em><\/li>\n\n\n\n
  148. \u00b7  Lee TW, Russell L, Deng M, Gibson PR (August 2013). “Association of doxycycline use with the development of gastroenteritis, irritable bowel syndrome and inflammatory bowel disease in Australians deployed abroad”. Internal Medicine Journal. 43<\/strong> (8): 919\u201326. doi<\/a>:10.1111\/imj.12179<\/a>. PMID<\/a> 23656210<\/a>. S2CID<\/a> 9418654<\/a>.<\/em><\/li>\n\n\n\n
  149. \u00b7  Margolis DJ, Fanelli M, Hoffstad O, Lewis JD (December 2010). “Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease”. The American Journal of Gastroenterology. 105<\/strong> (12): 2610\u20136. doi<\/a>:10.1038\/ajg.2010.303<\/a>. PMID<\/a> 20700115<\/a>. S2CID<\/a> 20085592<\/a>.<\/em><\/li>\n\n\n\n
  150. \u00b7  Garrett JP, Margolis DJ (March 2012). “Impact of Long-Term Antibiotic Use for Acne on Bacterial Ecology and Health Outcomes: A Review of Observational Studies”<\/a>. Current Dermatology Reports. 1<\/strong> (1): 23\u201328. doi<\/a>:10.1007\/s13671-011-0001-7<\/a>.<\/em><\/li>\n\n\n\n
  151. \u00b7  Elson CO, Cong Y, Weaver CT, Schoeb TR, McClanahan TK, Fick RB, Kastelein RA (2007). “Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice”. Gastroenterology. 132<\/strong> (7): 2359\u201370. doi<\/a>:10.1053\/j.gastro.2007.03.104<\/a>. PMID<\/a> 17570211<\/a>.<\/em><\/li>\n\n\n\n
  152. \u00b7  Crawford JM. “The Gastrointestinal tract, Chapter 17”. In Cotran RS, Kumar V, Robbins SL. Robbins Pathologic Basis of Disease: 5th Edition<\/em>. W.B. Saunders and Company, Philadelphia, 1994.<\/li>\n\n\n\n
  153. \u00b7  Zhang T, DeSimone RA, Jiao X, Rohlf FJ, Zhu W, Gong QQ, et al. (June 13, 2012). “Host genes related to paneth cells and xenobiotic metabolism are associated with shifts in human ileum-associated microbial composition”<\/a>. PLOS ONE. 7<\/strong> (6): e30044. Bibcode<\/a>:2012PLoSO…730044Z<\/a>. doi<\/a>:10.1371\/journal.pone.0030044<\/a>. PMC<\/a> 3374611<\/a>. PMID<\/a> 22719822<\/a>.<\/em><\/li>\n\n\n\n
  154. \u00b7  HCP: Pill Cam, Capsule Endoscopy, Esophageal Endoscopy<\/a> Archived<\/a> June 16, 2008, at the Wayback Machine<\/a><\/li>\n\n\n\n
  155. \u00b7  Scheinfeld NS, Teplitz E, McClain SA (November 2001). “Crohn’s disease and lichen nitidus: a case report and comparison of common histopathologic features”<\/a>. Inflammatory Bowel Diseases. 7<\/strong> (4): 314\u20138. doi<\/a>:10.1097\/00054725-200111000-00006<\/a>. PMID<\/a> 11720321<\/a>. S2CID<\/a> 35892792<\/a>.<\/em><\/li>\n\n\n\n
  156. \u00b7  Tan WC, Allan RN (October 1993). “Diffuse jejunoileitis of Crohn’s disease”<\/a>. Gut. 34<\/strong> (10): 1374\u20138. doi<\/a>:10.1136\/gut.34.10.1374<\/a>. PMC<\/a> 1374544<\/a>. PMID<\/a> 8244104<\/a>.<\/em><\/li>\n\n\n\n
  157. \u00b7  Gasche C, Scholmerich J, Brynskov J, D’Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR (February 2000). “A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998”. Inflammatory Bowel Diseases. 6<\/strong> (1): 8\u201315. doi<\/a>:10.1002\/ibd.3780060103<\/a>. PMID<\/a> 10701144<\/a>.<\/em><\/li>\n\n\n\n
  158. \u00b7  Dubinsky MC, Fleshner PP (June 2003). “Treatment of Crohn’s Disease of Inflammatory, Stenotic, and Fistulizing Phenotypes”. Current Treatment Options in Gastroenterology. 6<\/strong> (3): 183\u2013200. doi<\/a>:10.1007\/s11938-003-0001-1<\/a>. PMID<\/a> 12744819<\/a>. S2CID<\/a> 21302609<\/a>.<\/em><\/li>\n\n\n\n
  159. \u00b7  Hara AK, Leighton JA, Heigh RI, Sharma VK, Silva AC, De Petris G, Hentz JG, Fleischer DE (January 2006). “Crohn disease of the small bowel: preliminary comparison among CT enterography, capsule endoscopy, small-bowel follow-through, and ileoscopy”. Radiology. 238<\/strong> (1): 128\u201334. doi<\/a>:10.1148\/radiol.2381050296<\/a>. PMID<\/a> 16373764<\/a>.<\/em><\/li>\n\n\n\n
  160. \u00b7  Triester SL, Leighton JA, Leontiadis GI, Gurudu SR, Fleischer DE, Hara AK, Heigh RI, Shiff AD, Sharma VK (May 2006). “A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with non-stricturing small bowel Crohn’s disease”. The American Journal of Gastroenterology. 101<\/strong> (5): 954\u201364. doi<\/a>:10.1111\/j.1572-0241.2006.00506.x<\/a>. PMID<\/a> 16696781<\/a>. S2CID<\/a> 25684863<\/a>.<\/em><\/li>\n\n\n\n
  161. \u00b7  Dixon PM, Roulston ME, Nolan DJ (January 1993). “The small bowel enema: a ten year review”. Clinical Radiology. 47<\/strong> (1): 46\u20138. doi<\/a>:10.1016\/S0009-9260(05)81213-9<\/a>. PMID<\/a> 8428417<\/a>.<\/em><\/li>\n\n\n\n
  162. \u00b7  Carucci LR, Levine MS (March 2002). “Radiographic imaging of inflammatory bowel disease”. Gastroenterology Clinics of North America. 31<\/strong> (1): 93\u2013117, ix. doi<\/a>:10.1016\/S0889-8553(01)00007-3<\/a>. PMID<\/a> 12122746<\/a>.<\/em><\/li>\n\n\n\n
  163. \u00b7  Rajesh A, Maglinte DD (January 2006). “Multislice CT enteroclysis: technique and clinical applications”. Clinical Radiology. 61<\/strong> (1): 31\u20139. doi<\/a>:10.1016\/j.crad.2005.08.006<\/a>. PMID<\/a> 16356814<\/a>.<\/em><\/li>\n\n\n\n
  164. \u00b7  Zissin R, Hertz M, Osadchy A, Novis B, Gayer G (February 2005). “Computed tomographic findings of abdominal complications of Crohn’s disease–pictorial essay”<\/a>. Canadian Association of Radiologists Journal. 56<\/strong> (1): 25\u201335. PMID<\/a> 15835588<\/a>. Archived<\/a> from the original on October 7, 2022. Retrieved May 18, 2022.<\/em><\/li>\n\n\n\n
  165. \u00b7  Mackalski BA, Bernstein CN (May 2006). “New diagnostic imaging tools for inflammatory bowel disease”<\/a>. Gut. 55<\/strong> (5): 733\u201341. doi<\/a>:10.1136\/gut.2005.076612<\/a>. PMC<\/a> 1856109<\/a>. PMID<\/a> 16609136<\/a>.<\/em><\/li>\n\n\n\n
  166. \u00b7  Sinha R, Rajiah P, Murphy P, Hawker P, Sanders S (October 2009). “Utility of high-resolution MR imaging in demonstrating transmural pathologic changes in Crohn disease”. Radiographics. 29<\/strong> (6): 1847\u201367. doi<\/a>:10.1148\/rg.296095503<\/a>. PMID<\/a> 19959525<\/a>.<\/em><\/li>\n\n\n\n
  167. \u00b7  Sinha R, Rajiah P, Ramachandran I, Sanders S, Murphy PD (May 2013). “Diffusion-weighted MR imaging of the gastrointestinal tract: technique, indications, and imaging findings”<\/a>. Radiographics. 33<\/strong> (3): 655\u201376, discussion 676\u201380. doi<\/a>:10.1148\/rg.333125042<\/a>. PMID<\/a> 23674768<\/a>.<\/em><\/li>\n\n\n\n
  168. \u00b7  Goh J, O’Morain CA (February 2003). “Review article: nutrition and adult inflammatory bowel disease”<\/a>. Alimentary Pharmacology & Therapeutics. 17<\/strong> (3): 307\u201320. doi<\/a>:10.1046\/j.1365-2036.2003.01482.x<\/a>. PMID<\/a> 12562443<\/a>. S2CID<\/a> 72099458<\/a>.<\/em><\/li>\n\n\n\n
  169. \u00b7  Chamouard P, Richert Z, Meyer N, Rahmi G, Baumann R (July 2006). “Diagnostic value of C-reactive protein for predicting activity level of Crohn’s disease”. Clinical Gastroenterology and Hepatology. 4<\/strong> (7): 882\u20137. doi<\/a>:10.1016\/j.cgh.2006.02.003<\/a>. PMID<\/a> 16630759<\/a>.<\/em><\/li>\n\n\n\n
  170. \u00b7  Kaila B, Orr K, Bernstein CN (December 2005). “The anti-Saccharomyces cerevisiae antibody assay in a province-wide practice: accurate in identifying cases of Crohn’s disease and predicting inflammatory disease”<\/a>. Canadian Journal of Gastroenterology. 19<\/strong> (12): 717\u201321. doi<\/a>:10.1155\/2005\/147681<\/a>. PMID<\/a> 16341311<\/a>.<\/em><\/li>\n\n\n\n
  171. \u00b7  Israeli E, Grotto I, Gilburd B, Balicer RD, Goldin E, Wiik A, Shoenfeld Y (September 2005). “Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease”<\/a>. Gut. 54<\/strong> (9): 1232\u20136. doi<\/a>:10.1136\/gut.2004.060228<\/a>. PMC<\/a> 1774672<\/a>. PMID<\/a> 16099791<\/a>.<\/em><\/li>\n\n\n\n
  172. \u00b7  Ferrante M, Henckaerts L, Joossens M, Pierik M, Joossens S, Dotan N, Norman GL, Altstock RT, Van Steen K, Rutgeerts P, Van Assche G, Vermeire S (October 2007). “New serological markers in inflammatory bowel disease are associated with complicated disease behaviour”<\/a>. Gut. 56<\/strong> (10): 1394\u2013403. doi<\/a>:10.1136\/gut.2006.108043<\/a>. PMC<\/a> 2000264<\/a>. PMID<\/a> 17456509<\/a>.<\/em><\/li>\n\n\n\n
  173. \u00b7  Papp M, Altorjay I, Dotan N, Palatka K, Foldi I, Tumpek J, et al. (March 2008). “New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2\/CARD15 genotype in a Hungarian IBD cohort”. The American Journal of Gastroenterology. 103<\/strong> (3): 665\u201381. doi<\/a>:10.1111\/j.1572-0241.2007.01652.x<\/a>. PMID<\/a> 18047543<\/a>. S2CID<\/a> 6015339<\/a>.<\/em><\/li>\n\n\n\n
  174. \u00b7  Seow CH, Stempak JM, Xu W, Lan H, Griffiths AM, Greenberg GR, Steinhart AH, Dotan N, Silverberg MS (June 2009). “Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype”. The American Journal of Gastroenterology. 104<\/strong> (6): 1426\u201334. doi<\/a>:10.1038\/ajg.2009.79<\/a>. PMID<\/a> 19491856<\/a>. S2CID<\/a> 25021606<\/a>.<\/em><\/li>\n\n\n\n
  175. \u00b7  Dotan I (December 2007). “Serologic markers in inflammatory bowel disease: tools for better diagnosis and disease stratification”. Expert Review of Gastroenterology & Hepatology. 1<\/strong> (2): 265\u201374. doi<\/a>:10.1586\/17474124.1.2.265<\/a>. PMID<\/a> 19072419<\/a>. S2CID<\/a> 32035337<\/a>.<\/em><\/li>\n\n\n\n
  176. \u00b7  Del Pinto R, Pietropaoli D, Chandar AK, Ferri C, Cominelli F (November 2015). “Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis”<\/a>. Inflammatory Bowel Diseases. 21<\/strong> (11): 2708\u201317. doi<\/a>:10.1097\/MIB.0000000000000546<\/a>. PMC<\/a> 4615394<\/a>. PMID<\/a> 26348447<\/a>.<\/em><\/li>\n\n\n\n
  177. \u00b7  Hanauer SB, Sandborn W (March 2001). “Management of Crohn’s disease in adults”<\/a>. The American Journal of Gastroenterology. 96<\/strong> (3): 635\u201343. doi<\/a>:10.1111\/j.1572-0241.2001.3671_c.x<\/a> (inactive August 1, 2023). PMID<\/a> 11280528<\/a>. S2CID<\/a> 31219115<\/a>.<\/em><\/li>\n\n\n\n
  178. \u00b7  Broom\u00e9 U, Bergquist A (February 2006). “Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer”. Seminars in Liver Disease. 26<\/strong> (1): 31\u201341. doi<\/a>:10.1055\/s-2006-933561<\/a>. PMID<\/a> 16496231<\/a>.<\/em><\/li>\n\n\n\n
  179. \u00b7  Baumgart DC, Sandborn WJ (May 2007). “Inflammatory bowel disease: clinical aspects and established and evolving therapies”. Lancet. 369<\/strong> (9573): 1641\u201357. doi<\/a>:10.1016\/S0140-6736(07)60751-X<\/a>. PMID<\/a> 17499606<\/a>. S2CID<\/a> 35264387<\/a>.<\/em><\/li>\n\n\n\n
  180. \u00b7  Shepherd NA (August 2002). “Granulomas in the diagnosis of intestinal Crohn’s disease: a myth exploded?”. Histopathology. 41<\/strong> (2): 166\u20138. doi<\/a>:10.1046\/j.1365-2559.2002.01441.x<\/a>. PMID<\/a> 12147095<\/a>. S2CID<\/a> 36907992<\/a>.<\/em><\/li>\n\n\n\n
  181. \u00b7  Mahadeva U, Martin JP, Patel NK, Price AB (July 2002). “Granulomatous ulcerative colitis: a re-appraisal of the mucosal granuloma in the distinction of Crohn’s disease from ulcerative colitis”. Histopathology. 41<\/strong> (1): 50\u20135. doi<\/a>:10.1046\/j.1365-2559.2002.01416.x<\/a>. PMID<\/a> 12121237<\/a>. S2CID<\/a> 29476514<\/a>.<\/em><\/li>\n\n\n\n
  182. \u00b7  DeRoche TC, Xiao SY, Liu X (August 2014). “Histological evaluation in ulcerative colitis”<\/a>. Gastroenterology Report. 2<\/strong> (3): 178\u201392. doi<\/a>:10.1093\/gastro\/gou031<\/a>. PMC<\/a> 4124271<\/a>. PMID<\/a> 24942757<\/a>.<\/em><\/li>\n\n\n\n
  183. \u00b7  Lewis NR, Scott BB (July 2006). “Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests)”<\/a>. Alimentary Pharmacology & Therapeutics (Review). 24<\/strong> (1): 47\u201354. doi<\/a>:10.1111\/j.1365-2036.2006.02967.x<\/a>. PMID<\/a> 16803602<\/a>. S2CID<\/a> 16823218<\/a>. Both the endomysial antibody and tissue transglutaminase antibody have very high sensitivities (93% for both) and specificities (>99% and >98% respectively) for the diagnosis of typical coeliac disease with villous atrophy. (…) As the detection of at least partial villous atrophy was used to make a diagnosis of coeliac disease in the vast majority of studies, we can’t assume that the same LRs apply to coeliac patients with lesser abnormality such as an increase in intraepithelial lymphocytes or electron-microscopic changes only. In fact, if such lesser abnormalities were used as criteria for diagnosing (and excluding) coeliac disease, the sensitivity of the tests could be lower (i.e. more false negatives), especially since a number of studies suggest that the EMA and tTG antibody tests are less sensitive with lesser degrees of mucosal abnormality<\/em><\/li>\n\n\n\n
  184. \u00b7  Rodrigo L, Garrote JA, Vivas S (September 2008). “[Celiac disease]”<\/a>. Medicina Clinica (Review) (in Spanish). 131<\/strong> (7): 264\u201370. doi<\/a>:10.1016\/S0025-7753(08)72247-4<\/a>. PMID<\/a> 18775218<\/a>. Archived from the original<\/a> on March 19, 2016. Retrieved March 13, 2016. Estos marcadores presentan en general una elevada sensibilidad y especificidad (cercanas al 90%) en presencia de atrofia marcada de las vellosidades intestinales. Sin embargo, muestran una notable disminuci\u00f3n de la sensibilidad (del orden del 40-50%) en casos con atrofia vellositaria leve o cambios m\u00ednimos. These markers generally have high sensitivity and specificity (around 90%) in the presence of marked atrophy of the villi. However, they show a marked decrease in sensitivity (of the order of 40-50%) in cases with mild villous atrophy or minimal changes.<\/em><\/li>\n\n\n\n
  185. \u00b7  Rostami Nejad M, Hogg-Kollars S, Ishaq S, Rostami K (2011). “Subclinical celiac disease and gluten sensitivity”<\/a>. Gastroenterology and Hepatology from Bed to Bench (Review). 4<\/strong> (3): 102\u20138. PMC<\/a> 4017418<\/a>. PMID<\/a> 24834166<\/a>.<\/em><\/li>\n\n\n\n
  186. \u00b7  Bold J, Rostami K (2011). “Gluten tolerance; potential challenges in treatment strategies”<\/a>. Gastroenterology and Hepatology from Bed to Bench (Review). 4<\/strong> (2): 53\u20137. PMC<\/a> 4017406<\/a>. PMID<\/a> 24834157<\/a>.<\/em><\/li>\n\n\n\n
  187. \u00b7  Agabegi ED, Agabegi SS (2008). “Inflammatory bowel disease (IBD)”. Step-Up to Medicine (Step-Up Series). Hagerstwon, MD: Lippincott Williams & Wilkins. pp. 152\u2013156. ISBN<\/a> 0-7817-7153-6<\/a>.<\/em><\/li>\n\n\n\n
  188. \u00b7  Feller M, Huwiler K, Schoepfer A, Shang A, Furrer H, Egger M (February 2010). “Long-term antibiotic treatment for Crohn’s disease: systematic review and meta-analysis of placebo-controlled trials”. Clinical Infectious Diseases. 50<\/strong> (4): 473\u201380. doi<\/a>:10.1086\/649923<\/a>. PMID<\/a> 20067425<\/a>.<\/em><\/li>\n\n\n\n
  189. \u00b7  Prantera C, Scribano ML (July 2009). “Antibiotics and probiotics in inflammatory bowel disease: why, when, and how”<\/a>. Current Opinion in Gastroenterology. 25<\/strong> (4): 329\u201333. doi<\/a>:10.1097\/MOG.0b013e32832b20bf<\/a>. PMID<\/a> 19444096<\/a>.<\/em><\/li>\n\n\n\n
  190. \u00b7  Fries WS, Nazario B (May 16, 2007). “Crohn’s Disease: 54 Tips to Help You Manage”<\/a>. WebMD<\/a>. Archived<\/a> from the original on February 8, 2008. Retrieved February 14, 2008.<\/em><\/li>\n\n\n\n
  191. \u00b7  Roncoroni L, Gori R, Elli L, Tontini GE, Doneda L, Norsa L, Cuomo M, Lombardo V, Scricciolo A, Caprioli F, Costantino A, Scaramella L, Vecchi M. Nutrition in Patients with Inflammatory Bowel Diseases: A Narrative Review. Nutrients. 2022 Feb 10;14(4):751<\/li>\n\n\n\n
  192. \u00b7  Ananthakrishnan AN, Kaplan GG, Bernstein CN, Burke KE, Lochhead PJ, Sasson AN, Agrawal M, Tiong JHT, Steinberg J, Kruis W, Steinwurz F, Ahuja V, Ng SC, Rubin DT, Colombel JF, Gearry R; International Organization for Study of Inflammatory Bowel Diseases. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus. Lancet Gastroenterol Hepatol. 2022 Apr 26:S2468-1253(22)00021-8.<\/li>\n\n\n\n
  193. \u00b7  Hou JK, Abraham B, El-Serag H (April 2011). “Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature”. The American Journal of Gastroenterology. 106<\/strong> (4): 563\u201373. doi<\/a>:10.1038\/ajg.2011.44<\/a>. PMID<\/a> 21468064<\/a>. S2CID<\/a> 10337669<\/a>.<\/em><\/li>\n\n\n\n
  194. \u00b7  Escott-Stump S (2008). Nutrition and Diagnosis-Related Care, 7th edition. Baltimore, MD: Lippincott Williams & Wilkins. pp. 1020 (pp 431). ISBN<\/a> 978-1-60831-017-3<\/a>.<\/em><\/li>\n\n\n\n
  195. \u00b7  Shanahan F (January 2002). “Crohn’s disease”. Lancet. 359<\/strong> (9300): 62\u20139. doi<\/a>:10.1016\/S0140-6736(02)07284-7<\/a>. PMID<\/a> 11809204<\/a>. S2CID<\/a> 743620<\/a>.<\/em><\/li>\n\n\n\n
  196. \u00b7  Djuri<\/em>\u0107<\/em> Z, <\/em>\u0160aranac L, Budi<\/em>\u0107<\/em> I, Pavlovi<\/em>\u0107<\/em> V, Djordjevi<\/em>\u0107<\/em> J (August 2018). “Therapeutic role of methotrexate in pediatric Crohn’s disease”<\/a>. Bosnian Journal of Basic Medical Sciences. 18<\/strong> (3): 211\u2013216. doi<\/a>:10.17305\/bjbms.2018.2792<\/a>. PMC<\/a> 6087553<\/a>. PMID<\/a> 29338679<\/a>.<\/em><\/li>\n\n\n\n
  197. \u00b7  “FDA Approves Cimzia to Treat Crohn’s Disease”<\/a> (Press release). Food and Drug Administration<\/a> (FDA). April 22, 2008. Archived<\/a> from the original on October 20, 2009. Retrieved November 5, 2009.<\/em><\/li>\n\n\n\n
  198. \u00b7  “Prescribing information ustekinumab”<\/a> (PDF). FDA. Archived<\/a> (PDF) from the original on October 18, 2020. Retrieved May 23, 2019.<\/em><\/li>\n\n\n\n
  199. \u00b7  Sandborn WJ, Colombel JF, Enns R, Feagan BG, Hanauer SB, Lawrance IC, et al. (International Efficacy of Natalizumab as Active Crohn’s Therapy (ENACT-1) Trial Group; Evaluation of Natalizumab as Continuous Therapy (ENACT-2) Trial Group) (November 2005). “Natalizumab induction and maintenance therapy for Crohn’s disease”<\/a>. The New England Journal of Medicine. 353<\/strong> (18): 1912\u201325. doi<\/a>:10.1056\/NEJMoa043335<\/a>. PMID<\/a> 16267322<\/a>.<\/em><\/li>\n\n\n\n
  200. \u00b7  Nelson SM, Nguyen TM, McDonald JW, MacDonald JK (August 2018). “Natalizumab for induction of remission in Crohn’s disease”<\/a>. The Cochrane Database of Systematic Reviews. 2018<\/strong> (8): CD006097. doi<\/a>:10.1002\/14651858.CD006097.pub3<\/a>. PMC<\/a> 6513248<\/a>. PMID<\/a> 30068022<\/a>.<\/em><\/li>\n\n\n\n
  201. \u00b7  “Discover RINVOQ\u00ae (upadacitinib)”<\/a>. RINVOQ. Archived<\/a> from the original on May 18, 2023. Retrieved May 29, 2023.<\/em><\/li>\n\n\n\n
  202. \u00b7  Longmore M, Wilkinson I, Turmezei T, Cheung CK (2007). Oxford Handbook of Clinical Medicine (7th ed.). Oxford University Press<\/a>. pp. 266\u20137. ISBN<\/a> 978-0-19-856837-7<\/a>.<\/em><\/li>\n\n\n\n
  203. \u00b7  MacDonald JK, Nguyen TM, Khanna R, Timmer A (November 2016). “Anti-IL-12\/23p40 antibodies for induction of remission in Crohn’s disease”<\/a>. The Cochrane Database of Systematic Reviews. 2016<\/strong> (11): CD007572. doi<\/a>:10.1002\/14651858.CD007572.pub3<\/a>. PMC<\/a> 6464484<\/a>. PMID<\/a> 27885650<\/a>.<\/em><\/li>\n\n\n\n
  204. \u00b7  Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, Mitton S, Orchard T, Rutter M, Younge L, Lees C, Ho GT, Satsangi J, Bloom S, et al. (IBD Section of the British Society of Gastroenterology) (May 2011). “Guidelines for the management of inflammatory bowel disease in adults”. Gut. 60<\/strong> (5): 571\u2013607. doi<\/a>:10.1136\/gut.2010.224154<\/a>. PMID<\/a> 21464096<\/a>. S2CID<\/a> 8269837<\/a>.<\/em><\/li>\n\n\n\n
  205. \u00b7  Goddard AF, James MW, McIntyre AS, Scott BB (October 2011). “Guidelines for the management of iron deficiency anaemia”<\/a>. Gut. 60<\/strong> (10): 1309\u201316. doi<\/a>:10.1136\/gut.2010.228874<\/a>. PMID<\/a> 21561874<\/a>.<\/em><\/li>\n\n\n\n
  206. \u00b7  Gasche C, Berstad A, Befrits R, Beglinger C, Dignass A, Erichsen K, et al. (December 2007). “Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases”<\/a>. Inflammatory Bowel Diseases. 13<\/strong> (12): 1545\u201353. doi<\/a>:10.1002\/ibd.20285<\/a>. PMID<\/a> 17985376<\/a>.<\/em><\/li>\n\n\n\n
  207. \u00b7  Beaugerie, L.; Itzkowitz, S.H. Cancers complicating inflammatory bowel disease. N. Engl. J. Med. 2015, 372, 1441\u20131452<\/li>\n\n\n\n
  208. \u00b7  Toruner, M.; Loftus, E.V.; Harmsen, W.S.; Zinsmeister, A.R.; Orenstein, R.; Sandborn, W.J.; Colombel, J.; Egan, L.J. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 2008, 134, 929\u2013936<\/li>\n\n\n\n
  209. \u00b7  Farraye, F.A.; Melmed, G.Y.; Lichtenstein, G.R.; Kane, S.V. ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease. Am. J. Gastroenterol. 2017, 112, 241\u2013258.<\/li>\n\n\n\n
  210. \u00b7  Kucharzik, T.; Ellul, P.; Greuter, T.; Rahier, J.F.; Verstockt, B.; Abreu, C.; Albuquerque, A.; Allocca, M.; Esteve, M.; Farraye, F.A.; et al. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. J. Crohn\u2019s Colitis 2021, 15, 879\u2013913.<\/li>\n\n\n\n
  211. \u00b7  Ananthakrishnan, A.N.; McGinley, E.L. Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases. J. Crohn\u2019s Colitis 2013, 7, 107\u2013112.<\/li>\n\n\n\n
  212. \u00b7  Malhi, G.; Rumman, A.; Thanabalan, R.; Croitoru, K.; Silverberg, M.S.; Steinhart, A.H.; Nguyen, G.C. Vaccination in inflammatory bowel disease patients: Attitudes, knowledge, and uptake. J. Crohn\u2019s Colitis 2015, 9, 439\u2013444.<\/li>\n\n\n\n
  213. \u00b7  Costantino, A.; Michelon, M.; Noviello, D.; Macaluso, F.S.; Leone, S.; Bonaccorso, N.; Costantino, C.; Vecchi, M.; Caprioli, F., on behalf of AMICI Scientific Board. Attitudes towards Vaccinations in a National Italian Cohort of Patients with Inflammatory Bowel Disease. Vaccines 2023, 11, 1591.<\/li>\n\n\n\n
  214. \u00b7  Kristo I, Stift A, Bergmann M, Riss S (May 2015). “Surgical recurrence in Crohn’s disease: Are we getting better?”<\/a>. World Journal of Gastroenterology. 21<\/strong> (20): 6097\u2013100. doi<\/a>:10.3748\/wjg.v21.i20.6097<\/a>. PMC<\/a> 4445088<\/a>. PMID<\/a> 26034346<\/a>.<\/em><\/li>\n\n\n\n
  215. \u00b7  Tresca AJ (January 12, 2007). “Resection Surgery for Crohn’s Disease”<\/a>. About.com<\/a>. Archived<\/a> from the original on November 13, 2007. Retrieved February 14, 2008.<\/em><\/li>\n\n\n\n
  216. \u00b7  Ozuner G, Fazio VW, Lavery IC, Milsom JW, Strong SA (November 1996). “Reoperative rates for Crohn’s disease following strictureplasty. Long-term analysis”. Diseases of the Colon and Rectum. 39<\/strong> (11): 1199\u2013203. doi<\/a>:10.1007\/BF02055108<\/a>. PMID<\/a> 8918424<\/a>. S2CID<\/a> 33628350<\/a>.<\/em><\/li>\n\n\n\n
  217. \u00b7  Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M (October 1990). “Predictability of the postoperative course of Crohn’s disease”<\/a>. Gastroenterology. 99<\/strong> (4): 956\u201363. doi<\/a>:10.1016\/0016-5085(90)90613-6<\/a>. PMID<\/a> 2394349<\/a>.<\/em><\/li>\n\n\n\n
  218. \u00b7  Yamamoto T, Bamba T, Umegae S, Matsumoto K (August 2013). “The impact of early endoscopic lesions on the clinical course of patients following ileocolonic resection for Crohn’s disease: A 5-year prospective cohort study”<\/a>. United European Gastroenterology Journal. 1<\/strong> (4): 294\u20138. doi<\/a>:10.1177\/2050640613495197<\/a>. PMC<\/a> 4040796<\/a>. PMID<\/a> 24917974<\/a>.<\/em><\/li>\n\n\n\n
  219. \u00b7  “Short Bowel Syndrome”<\/a>. National Institute of Diabetes and Digestive and Kidney Diseases<\/a> (NIDDK). July 2015. Archived from the original<\/a> on December 9, 2019. Retrieved December 8, 2019.<\/em><\/li>\n\n\n\n
  220. \u00b7  Rhodes M (October 24, 2006). “Intestinal transplant for Crohn’s disease”<\/a>. Everyday Health. Archived<\/a> from the original on October 8, 2008. Retrieved March 22, 2009.<\/em><\/li>\n\n\n\n
  221. \u00b7  Hofmann AF (April 1967). “The syndrome of ileal disease and the broken enterohepatic circulation: cholerheic enteropathy”<\/a>. Gastroenterology. 52<\/strong> (4): 752\u20137. doi<\/a>:10.1016\/S0016-5085(67)80140-9<\/a>. PMID<\/a> 5337211<\/a>.<\/em><\/li>\n\n\n\n
  222. \u00b7  Limketkai, Berkeley N; Akobeng, Anthony K; Gordon, Morris; Adepoju, Akinlolu Adedayo (July 17, 2020). Cochrane Gut Group (ed.). “Probiotics for induction of remission in Crohn’s disease”<\/a>. Cochrane Database of Systematic Reviews. 2020<\/strong> (7): CD006634. doi<\/a>:10.1002\/14651858.CD006634.pub3<\/a>. PMC<\/a> 7389339<\/a>. PMID<\/a> 32678465<\/a>.<\/em><\/li>\n\n\n\n
  223. \u00b7  Szigethy E, McLafferty L, Goyal A (April 2010). “Inflammatory bowel disease”<\/a>. Child and Adolescent Psychiatric Clinics of North America (Submitted manuscript). 19<\/strong> (2): 301\u201318, ix. doi<\/a>:10.1016\/j.chc.2010.01.007<\/a>. PMID<\/a> 20478501<\/a>. Archived<\/a> from the original on April 28, 2021. Retrieved September 4, 2018.<\/em><\/li>\n\n\n\n
  224. \u00b7  Ballou S, Keefer L (January 2017). “Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases”<\/a>. Clinical and Translational Gastroenterology. 8<\/strong> (1): e214. doi<\/a>:10.1038\/ctg.2016.69<\/a>. PMC<\/a> 5288603<\/a>. PMID<\/a> 28102860<\/a>.<\/em><\/li>\n\n\n\n
  225. \u00b7  Caprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, et al. (European Crohn’s Colitis Organisation) (March 2006). “European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations”<\/a>. Gut. 55<\/strong> (Suppl 1): i36\u201358. doi<\/a>:10.1136\/gut.2005.081950c<\/a>. PMC<\/a> 1859996<\/a>. PMID<\/a> 16481630<\/a>. the colitis activity index fell significantly in the treatment group compared to the sham acupuncture group. However, recruitment did not reach its target and the number of patients was small.<\/em><\/li>\n\n\n\n
  226. \u00b7  Joos S, Brinkhaus B, Maluche C, Maupai N, Kohnen R, Kraehmer N, Hahn EG, Schuppan D (2004). “Acupuncture and moxibustion in the treatment of active Crohn’s disease: a randomized controlled study”. Digestion. 69<\/strong> (3): 131\u20139. doi<\/a>:10.1159\/000078151<\/a>. PMID<\/a> 15114043<\/a>. S2CID<\/a> 7852406<\/a>.<\/em><\/li>\n\n\n\n
  227. \u00b7  Joos S (June 2011). “Review on efficacy and health services research studies of complementary and alternative medicine in inflammatory bowel disease”. Chinese Journal of Integrative Medicine. 17<\/strong> (6): 403\u20139. doi<\/a>:10.1007\/s11655-011-0758-3<\/a>. PMID<\/a> 21660673<\/a>. S2CID<\/a> 207298246<\/a>.<\/em><\/li>\n\n\n\n
  228. \u00b7  Smith K (2012). “Homeopathy is Unscientific and Unethical”<\/a>. Bioethics. 26<\/strong> (9): 508\u2013512. doi<\/a>:10.1111\/j.1467-8519.2011.01956.x<\/a>. S2CID<\/a> 143067523<\/a>. Archived<\/a> from the original on October 29, 2017. Retrieved October 28, 2017.<\/em><\/li>\n\n\n\n
  229. \u00b7  Ladyman J (2013). “Towards a Demarcation of Science from Pseudoscience”<\/a>. In Pigliucci M, Boudry M (eds.). Philosophy of Pseudoscience: Reconsidering the Demarcation Problem. University of Chicago Press<\/a>. pp. 45\u201359. ISBN<\/a> 978-0-226-05182-6<\/a>. Yet homeopathy is a paradigmatic example of pseudoscience. It is neither simply bad science nor science fraud, but rather profoundly departs from scientific method and theories while being described as scientific by some of its adherents (often sincerely).<\/em><\/li>\n\n\n\n
  230. \u00b7  Baran GR, Kiani MF, Samuel SP (2014). “Science, Pseudoscience, and Not Science: How do They Differ?”<\/a>. Healthcare and Biomedical Technology in the 21st Century. pp. 19\u201357. doi<\/a>:10.1007\/978-1-4614-8541-4_2<\/a>. ISBN<\/a> 978-1-4614-8540-7<\/a>. within the traditional medical community it is considered to be quackery<\/em><\/li>\n\n\n\n
  231. \u00b7  Ernst E<\/a> (December 2002). “A systematic review of systematic reviews of homeopathy”<\/a>. British Journal of Clinical Pharmacology. 54<\/strong> (6): 577\u201382. doi<\/a>:10.1046\/j.1365-2125.2002.01699.x<\/a>. PMC<\/a> 1874503<\/a>. PMID<\/a> 12492603<\/a>.<\/em><\/li>\n\n\n\n
  232. \u00b7  Shang A, Huwiler-M\u00fcntener K, Nartey L, J\u00fcni P, D\u00f6rig S, Sterne JA, Pewsner D, Egger M (2005). “Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy”. Lancet. 366<\/strong> (9487): 726\u201332. doi<\/a>:10.1016\/S0140-6736(05)67177-2<\/a>. PMID<\/a> 16125589<\/a>. S2CID<\/a> 17939264<\/a>.<\/em><\/li>\n\n\n\n
  233. \u00b7  “Evidence Check 2: Homeopathy – Science and Technology Committee”<\/a>. British House of Commons<\/a> Science and Technology Committee. February 22, 2010. Archived<\/a> from the original on September 19, 2015. Retrieved April 5, 2014.<\/em><\/li>\n\n\n\n
  234. \u00b7  Naftali T, Mechulam R, Lev LB, Konikoff FM (2014). “Cannabis for inflammatory bowel disease”. Digestive Diseases. 32<\/strong> (4): 468\u201374. doi<\/a>:10.1159\/000358155<\/a>. PMID<\/a> 24969296<\/a>. S2CID<\/a> 25309621<\/a>.<\/em><\/li>\n\n\n\n
  235. \u00b7  Kafil TS, Nguyen TM, MacDonald JK, Chande N (November 2018). “Cannabis for the treatment of Crohn’s disease”<\/a>. The Cochrane Database of Systematic Reviews. 11<\/strong> (11): CD012853. doi<\/a>:10.1002\/14651858.CD012853.pub2<\/a>. PMC<\/a> 6517156<\/a>. PMID<\/a> 30407616<\/a>.<\/em><\/li>\n\n\n\n
  236. \u00b7  “Crohn’s disease – Prognosis”<\/a>. University of Maryland Medical Centre<\/a>. Archived<\/a> from the original on August 29, 2012. Retrieved October 19, 2012.<\/em><\/li>\n\n\n\n
  237. \u00b7  Canavan C, Abrams KR, Mayberry J (April 2006). “Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease”<\/a>. Alimentary Pharmacology & Therapeutics. 23<\/strong> (8): 1097\u2013104. doi<\/a>:10.1111\/j.1365-2036.2006.02854.x<\/a>. PMID<\/a> 16611269<\/a>. S2CID<\/a> 25193522<\/a>.<\/em><\/li>\n\n\n\n
  238. \u00b7  Hiatt RA, Kaufman L (November 1988). “Epidemiology of inflammatory bowel disease in a defined northern California population”<\/a>. The Western Journal of Medicine. 149<\/strong> (5): 541\u20136. PMC<\/a> 1026530<\/a>. PMID<\/a> 3250100<\/a>.<\/em><\/li>\n\n\n\n
  239. \u00b7  Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, Stray N, Sauar J, Schulz T (April 1996). “Incidence of Crohn’s disease in four counties in southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists”. Scandinavian Journal of Gastroenterology. 31<\/strong> (4): 355\u201361. doi<\/a>:10.3109\/00365529609006410<\/a>. PMID<\/a> 8726303<\/a>.<\/em><\/li>\n\n\n\n
  240. \u00b7  Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M (November 1996). “Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD)”<\/a>. Gut. 39<\/strong> (5): 690\u20137. doi<\/a>:10.1136\/gut.39.5.690<\/a>. PMC<\/a> 1383393<\/a>. PMID<\/a> 9014768<\/a>.<\/em><\/li>\n\n\n\n
  241. \u00b7  Yang H, McElree C, Roth MP, Shanahan F, Targan SR, Rotter JI (April 1993). “Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews”<\/a>. Gut. 34<\/strong> (4): 517\u201324. doi<\/a>:10.1136\/gut.34.4.517<\/a>. PMC<\/a> 1374314<\/a>. PMID<\/a> 8491401<\/a>.<\/em><\/li>\n\n\n\n
  242. \u00b7  Seksik P, Nion-Larmurier I, Sokol H, Beaugerie L, Cosnes J (May 2009). “Effects of light smoking consumption on the clinical course of Crohn’s disease”<\/a>. Inflammatory Bowel Diseases. 15<\/strong> (5): 734\u201341. doi<\/a>:10.1002\/ibd.20828<\/a>. PMID<\/a> 19067428<\/a>. S2CID<\/a> 10988974<\/a>.<\/em><\/li>\n\n\n\n
  243. \u00b7  “Crohn’s disease manifests differently in boys and girls”<\/a>. Crohn’s and Colitis Foundation of America<\/a>. Archived from the original<\/a> on February 16, 2008.<\/em><\/li>\n\n\n\n
  244. \u00b7  “Who is affected by Crohn’s disease”<\/a>. Healthwise. Archived from the original<\/a> on January 23, 2009.<\/em><\/li>\n\n\n\n
  245. \u00b7  Satsangi J, Jewell DP, Bell JI (May 1997). “The genetics of inflammatory bowel disease”<\/a>. Gut. 40<\/strong> (5): 572\u20134. doi<\/a>:10.1136\/gut.40.5.572<\/a>. PMC<\/a> 1027155<\/a>. PMID<\/a> 9203931<\/a>.<\/em><\/li>\n\n\n\n
  246. \u00b7  Tysk C, Lindberg E, J\u00e4rnerot G, Flod\u00e9rus-Myrhed B (July 1988). “Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking”<\/a>. Gut. 29<\/strong> (7): 990\u20136. doi<\/a>:10.1136\/gut.29.7.990<\/a>. PMC<\/a> 1433769<\/a>. PMID<\/a> 3396969<\/a>.<\/em><\/li>\n\n\n\n
  247. \u00b7  Burisch J, Jess T, Martinato M, Lakatos PL (May 2013). “The burden of inflammatory bowel disease in Europe”<\/a>. Journal of Crohn’s & Colitis. 7<\/strong> (4): 322\u201337. doi<\/a>:10.1016\/j.crohns.2013.01.010<\/a>. PMID<\/a> 23395397<\/a>.<\/em><\/li>\n\n\n\n
  248. \u00b7  Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JC, Chan FK, Sung JJ, Kaplan GG (December 2018). “Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies”<\/a>. Lancet. 390<\/strong> (10114): 2769\u20132778. doi<\/a>:10.1016\/S0140-6736(17)32448-0<\/a>. PMID<\/a> 29050646<\/a>. S2CID<\/a> 32940<\/a>.<\/em><\/li>\n\n\n\n
  249. \u00b7  Kirsner JB (June 1988). “Historical aspects of inflammatory bowel disease”. Journal of Clinical Gastroenterology. 10<\/strong> (3): 286\u201397. doi<\/a>:10.1097\/00004836-198806000-00012<\/a>. PMID<\/a> 2980764<\/a>.<\/em><\/li>\n\n\n\n
  250. \u00b7  Lichtarowicz AM, Mayberry JF (August 1988). “Antoni L\u00e9sniowski and his contribution to regional enteritis (Crohn’s disease)”<\/a>. Journal of the Royal Society of Medicine. 81<\/strong> (8): 468\u201370. doi<\/a>:10.1177\/014107688808100817<\/a>. PMC<\/a> 1291720<\/a>. PMID<\/a> 3047387<\/a>.<\/em><\/li>\n<\/ol>\n\n\n\n

    3. \u5ef6\u4f38\u9605\u8bfb Further Reading<\/h2>\n\n\n\n

    Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE (April 2018). “ACG Clinical Guideline: Management of Crohn’s Disease in Adults”<\/a>. Am. J. Gastroenterol<\/em>. 113<\/strong> (4): 481\u2013517. doi<\/a>:10.1038\/ajg.2018.27<\/a>. PMID<\/a>29610508<\/a>.<\/p>\n\n\n\n

    4. \u5916\u90e8\u94fe\u63a5 External Links<\/h2>\n\n\n\n